CD27	B-protein
/CD70	O
interaction	O
augments	O
IgE	B-protein
secretion	O
by	O
promoting	O
the	O
differentiation	O
of	O
memory	B-cell_type
B	I-cell_type
cells	I-cell_type
into	O
plasma	B-cell_type
cells	I-cell_type
.	O

The	O
induction	O
of	O
IgE	B-protein
switching	O
in	O
B	B-cell_type
cells	I-cell_type
requires	O
several	O
signals	O
given	O
by	O
cytokines	B-protein
and	O
cell	O
contact-delivered	O
signals	O
.	O

Here	O
,	O
we	O
investigated	O
the	O
role	O
of	O
CD27	B-protein
/CD70	O
interaction	O
in	O
B	O
cell	O
IgE	B-protein
synthesis	O
.	O

The	O
addition	O
of	O
CD27	O
ligand	O
(	O
CD70	O
)	O
transfectants	O
to	O
B	B-cell_line
cell	I-cell_line
cultures	I-cell_line
increased	O
the	O
IgE	B-protein
synthesis	O
synergistically	O
in	O
the	O
presence	O
of	O
IL-4	B-protein
plus	O
anti-CD40	B-protein
mAb	I-protein
(	O
anti-CD40	B-protein
)	O
.	O

The	O
effect	O
of	O
CD70	B-cell_line
transfectants	I-cell_line
was	O
dose	O
dependent	O
and	O
was	O
completely	O
blocked	O
by	O
anti-CD70	B-protein
mAb	I-protein
.	I-protein

CD27+	B-cell_type
B	I-cell_type
cells	I-cell_type
had	O
the	O
ability	O
to	O
produce	O
IgE	B-protein
,	O
which	O
was	O
increased	O
by	O
contact	O
with	O
CD70	O
transfectants	O
,	O
whereas	O
CD27-	O
B	O
cells	O
did	O
not	O
produce	O
IgE	B-protein
.	O

CD27	B-protein
/CD70	O
interaction	O
enhanced	O
B	B-cell_type
cell	I-cell_type
proliferation	O
in	O
the	O
presence	O
of	O
IL-4	B-protein
or	O
IL-4	B-protein
plus	O
anti-CD40	B-protein
.	O

The	O
augmentation	O
of	O
B	O
cell	O
proliferation	O
by	O
CD70	O
transfectants	O
was	O
apparent	O
in	O
CD27+	B-cell_type
B	I-cell_type
cells	I-cell_type
,	O
but	O
was	O
mild	O
in	O
CD27-	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

The	O
helper	O
activity	O
for	O
IgE	B-protein
synthesis	O
by	O
the	O
CD27	B-protein
/CD70	O
interaction	O
did	O
not	O
contribute	O
to	O
the	O
enhancement	O
of	O
germline	B-RNA
epsilon	I-RNA
transcripts	I-RNA
.	O

Flow	O
cytometric	O
and	O
morphological	O
analyses	O
demonstrated	O
that	O
the	O
addition	O
of	O
CD70	O
transfectants	O
to	O
B	B-cell_line
cell	I-cell_line
cultures	I-cell_line
remarkably	O
promoted	O
differentiation	O
into	O
plasma	B-cell_type
cells	I-cell_type
in	O
the	O
presence	O
of	O
IL-4	B-protein
and	O
CD40	B-protein
signaling	O
.	O

Finally	O
,	O
CD27	B-protein
cross-linking	O
resulted	O
in	O
the	O
up-regulation	O
of	O
positive	B-protein
regulatory	I-protein
domain	I-protein
I-binding	I-protein
factor-1	I-protein
.	O

Taken	O
together	O
,	O
our	O
findings	O
indicate	O
that	O
signaling	O
via	O
CD27	B-protein
on	O
B	B-cell_type
cells	I-cell_type
induces	O
IgE	B-protein
synthesis	O
,	O
in	O
cooperation	O
with	O
IL-4	B-protein
and	O
CD40	B-protein
signaling	O
,	O
by	O
promoting	O
the	O
generation	O
of	O
plasma	B-cell_type
cells	I-cell_type
through	O
up-regulation	O
of	O
positive	B-protein
regulatory	I-protein
domain	I-protein
I-binding	I-protein
factor-1	I-protein
.	O

``	NULL
n	NULL
vivo	NULL
,	NULL
RE	NULL
SEARCH	NULL
*	NULL
Discover	NULL
More	NULL
j	NULL
has	NULL
Rs	NULL
teJournal	NULL
o	NULL
CD27/CD70	NULL
Interaction	NULL
Augments	NULL
IgE	NULL
ééﬂégflmmunolo	NULL
gy	NULL
Secretion	NULL
by	NULL
Promoting	NULL
the	NULL
Differentiation	NULL
of	NULL
Memory	NULL
B	NULL
Cells	NULL
into	NULL
Plasma	NULL
Cells	NULL
BULLANTBODIE	NULL
-	NULL
CTSA	NULL
)	NULL
Cor	NULL
C25	NULL
'Can	NULL
3	NULL
)	NULL
This	NULL
inf	NULL
tion	NULL
i	NULL
t	NULL
Haruo	NULL
Nagumo	NULL
,	NULL
Kazunaga	NULL
Agematsu	NULL
,	NULL
Koji	NULL
Shinozaki	NULL
,	NULL
Sho	NULL
of	NULL
£1	NULL
:	NULL
le	NULL
(	NULL
Elana	NULL
;	NULL
i	NULL
)	NULL
;	NULL
Is	NULL
current	NULL
as	NULL
Hokibara	NULL
,	NULL
Susumu	NULL
Ito	NULL
,	NULL
Masaya	NULL
Takamoto	NULL
,	NULL
Toshio	NULL
Nikaido	NULL
,	NULL
'	NULL
Kozo	NULL
Yasui	NULL
,	NULL
Yoshio	NULL
Uehara	NULL
,	NULL
Akihiro	NULL
Yachie	NULL
and	NULL
Atsushi	NULL
Komiyama	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:6496-6502	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/12/6496	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
41	NULL
articles	NULL
,	NULL
32	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/12/6496.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
CD27/CD70	NULL
Interaction	NULL
Augments	NULL
IgE	NULL
Secretion	NULL
by	NULL
Promoting	NULL
the	NULL
Differentiation	NULL
of	NULL
Memory	NULL
B	NULL
Cells	NULL
into	NULL
Plasma	NULL
Cells	NULL
Haruo	NULL
Nagumo	NULL
,	NULL
*	NULL
Kazunaga	NULL
Koji	NULL
Shinozaki	NULL
,	NULL
*	NULL
Sho	NULL
Hokibara	NULL
,	NULL
*	NULL
Susumu	NULL
Ito	NULL
,	NULL
``	NULL
Masaya	NULL
Takamoto	NULL
,	NULL
*	NULL
Toshio	NULL
Nikaido	NULL
,	NULL
'	NULL
Kozo	NULL
Yasui	NULL
,	NULL
*	NULL
Yoshio	NULL
Uehara	NULL
,	NULL
``	NULL
Akihiro	NULL
Yachie	NULL
,	NULL
!	NULL

and	NULL
Atsushi	NULL
Komiyama*	NULL
The	NULL
induction	NULL
of	NULL
IgE	NULL
switching	NULL
in	NULL
B	NULL
cells	NULL
requires	NULL
several	NULL
signals	NULL
given	NULL
by	NULL
cytokines	NULL
and	NULL
cell	NULL
contact-delivered	NULL
signals	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
CD27/CD70	NULL
interaction	NULL
in	NULL
B	NULL
cell	NULL
IgE	NULL
synthesis	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
CD27	NULL
ligand	NULL
(	NULL
CD70	NULL
)	NULL
transfectants	NULL
to	NULL
B	NULL
cell	NULL
cultures	NULL
increased	NULL
the	NULL
IgE	NULL
synthesis	NULL
synergistically	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
mAb	NULL
(	NULL
anti-CD40	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
CD70	NULL
transfectants	NULL
was	NULL
dose	NULL
dependent	NULL
and	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
anti-CD70	NULL
mAb	NULL
.	NULL

CD27*	NULL
B	NULL
cells	NULL
had	NULL
the	NULL
ability	NULL
to	NULL
produce	NULL
IgE	NULL
,	NULL
which	NULL
was	NULL
increased	NULL
by	NULL
contact	NULL
with	NULL
CD70	NULL
transfectants	NULL
,	NULL
whereas	NULL
CD27	NULL
B	NULL
cells	NULL
did	NULL
not	NULL
produce	NULL
IgE	NULL
.	NULL

CD27/CD70	NULL
interaction	NULL
enhanced	NULL
B	NULL
cell	NULL
proliferation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
.	NULL

The	NULL
augmentation	NULL
of	NULL
B	NULL
cell	NULL
proliferation	NULL
by	NULL
CD70	NULL
transfectants	NULL
was	NULL
apparent	NULL
in	NULL
CD27*	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
was	NULL
mild	NULL
in	NULL
CD27~	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
helper	NULL
activity	NULL
for	NULL
IgE	NULL
synthesis	NULL
by	NULL
the	NULL
CD27/CD70	NULL
interaction	NULL
did	NULL
not	NULL
contribute	NULL
to	NULL
the	NULL
enhancement	NULL
of	NULL
germline	NULL
e	NULL
transcripts	NULL
.	NULL

Flow	NULL
cytometric	NULL
and	NULL
morphological	NULL
analyses	NULL
demonstrated	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
CD70	NULL
transfectants	NULL
to	NULL
B	NULL
cell	NULL
cultures	NULL
remarkably	NULL
promoted	NULL
differentiation	NULL
into	NULL
plasma	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
and	NULL
CD40	NULL
signaling	NULL
.	NULL

Finally	NULL
,	NULL
CD27	NULL
cross-linking	NULL
resulted	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
positive	NULL
regulatory	NULL
domain	NULL
I-binding	NULL
factor-1	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
findings	NULL
indicate	NULL
that	NULL
signaling	NULL
via	NULL
CD27	NULL
on	NULL
B	NULL
cells	NULL
induces	NULL
IgE	NULL
synthesis	NULL
,	NULL
in	NULL
cooperation	NULL
with	NULL
IL-4	NULL
and	NULL
CD40	NULL
signaling	NULL
,	NULL
by	NULL
promoting	NULL
the	NULL
generation	NULL
of	NULL
plasma	NULL
cells	NULL
through	NULL
up-regulation	NULL
of	NULL
positive	NULL
regu-	NULL
latory	NULL
domain	NULL
I-binding	NULL
factor-1	NULL
.	NULL

he	NULL
IgE	NULL
immune	NULL
response	NULL
is	NULL
an	NULL
important	NULL
event	NULL
in	NULL
vivo	NULL
because	NULL
it	NULL
may	NULL
lead	NULL
to	NULL
the	NULL
development	NULL
of	NULL
allergic	NULL
dis	NULL
eases	NULL
such	NULL
as	NULL
atopy	NULL
and	NULL
asthma	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
IgE	NULL
switching	NULL
in	NULL
B	NULL
cells	NULL
requires	NULL
at	NULL
least	NULL
two	NULL
signals	NULL
:	NULL
a	NULL
class	NULL
switching	NULL
factor	NULL
,	NULL
most	NULL
commonly	NULL
IL-4	NULL
,	NULL
and	NULL
the	NULL
engagement	NULL
of	NULL
CD40	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
IL-4	NULL
and	NULL
anti-CD40	NULL
mAb	NULL
can	NULL
stimulate	NULL
IgE	NULL
production	NULL
in	NULL
vitro	NULL
(	NULL
2-4	NULL
)	NULL
,	NULL
whereas	NULL
several	NULL
other	NULL
regulatory	NULL
molecules	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
B	NULL
cell	NULL
IgE	NULL
secretion	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

The	NULL
enhancement	NULL
of	NULL
IgE	NULL
synthesis	NULL
by	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
clones	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
CD40	NULL
signaling	NULL
suggest	NULL
a	NULL
different	NULL
B	NULL
cell	NULL
pathway	NULL
for	NULL
IgE	NULL
production	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Life	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
that	NULL
T	NULL
cell	NULL
clones	NULL
from	NULL
an	NULL
X-linked	NULL
hyper-IgM	NULL
syndrome	NULL
patient	NULL
induced	NULL
IgE	NULL
synthesis	NULL
in	NULL
vitro	NULL
despite	NULL
the	NULL
expression	NULL
of	NULL
nonfunctional	NULL
€D154	NULL
,	NULL
indicating	NULL
the	NULL
involvement	NULL
of	NULL
T	NULL
cell	NULL
surface	NULL
molecules	NULL
other	NULL
than	NULL
CD154	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IgE	NULL
synthesis	NULL
(	NULL
8	NULL
)	NULL
.	NULL

CD27	NULL
,	NULL
characterized	NULL
in	NULL
detail	NULL
by	NULL
van	NULL
Lier	NULL
et	NULL
al	NULL
.	NULL

(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
is	NULL
a	NULL
type	NULL
I	NULL
glycoprotein	NULL
expressed	NULL
on	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
B	NULL
cell	NULL
malignancies	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
CD27	NULL
,	NULL
which	NULL
belongs	NULL
to	NULL
the	NULL
nerve	NULL
growth	NULL
factor	NULL
receptor/	NULL
TNF	NULL
receptor	NULL
family	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
CD27	NULL
ligand	NULL
(	NULL
CD70	NULL
)	NULL
,	NULL
which	NULL
belongs	NULL
to	NULL
the	NULL
TNF	NULL
family	NULL
(	NULL
13	NULL
)	NULL
and	NULL
is	NULL
expressed	NULL
not	NULL
only	NULL
on	NULL
activated	NULL
B	NULL
but	NULL
also	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
especially	NULL
activated	NULL
CD4	NULL
*	NULL
CD4SRO	NULL
T	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
,	NULL
can	NULL
enhance	NULL
Ig	NULL
production	NULL
by	NULL
B	NULL
cells	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

In	NULL
Departments	NULL
of	NULL
*Pediatrics	NULL
,	NULL
*Blood	NULL
Transfusion	NULL
,	NULL
*Parasitology	NULL
,	NULL
and	NULL
Obstetrics	NULL
and	NULL
Gynecology	NULL
,	NULL
Shinshu	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Matsumoto	NULL
,	NULL
Japan	NULL
;	NULL
``	NULL
Nagano	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Toyoshina	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
HDepartment	NULL
of	NULL
Laboratory	NULL
Sciences	NULL
,	NULL
School	NULL
of	NULL
Health	NULL
Sciences	NULL
,	NULL
Faculty	NULL
of	NULL
Medicine	NULL
,	NULL
Kanazawa	NULL
University	NULL
,	NULL
Kanazawa	NULL
,	NULL
Japan	NULL
Received	NULL
for	NULL
publication	NULL
April	NULL
3	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
August	NULL
26	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Kazunaga	NULL
Agematsu	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Shinshu	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Asahi	NULL
3-1-1	NULL
,	NULL
Matsumoto	NULL
390-0802	NULL
,	NULL
Japan	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
agemats	NULL
@	NULL
gipac.shinshu-u.ac.jp	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
6496-6502.	NULL
addition	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
€CD27/CD70	NULL
interaction	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
into	NULL
plasma	NULL
cells	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
clarified	NULL
the	NULL
role	NULL
of	NULL
CD27/CD70	NULL
interaction	NULL
in	NULL
B	NULL
cell	NULL
IgE	NULL
synthesis	NULL
by	NULL
investigating	NULL
the	NULL
effects	NULL
of	NULL
CD27	NULL
signaling	NULL
on	NULL
B	NULL
cell	NULL
proliferation	NULL
,	NULL
germline	NULL
e	NULL
transcripts	NULL
,	NULL
differentiation	NULL
into	NULL
plasma	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
B	NULL
cell	NULL
differentiation	NULL
such	NULL
as	NULL
positive	NULL
regulatory	NULL
domain	NULL
[	NULL
-binding	NULL
factors	NULL
1	NULL
(	NULL
PRDI-BF1	NULL
}	NULL
``	NULL
and	NULL
B	NULL
cell-specific	NULL
activator	NULL
protein	NULL
(	NULL
BSAP	NULL
)	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Abs	NULL
and	NULL
reagents	NULL
Anti-CD27	NULL
mAb	NULL
(	NULL
8H5	NULL
;	NULL
IgG1	NULL
)	NULL
,	NULL
which	NULL
does	NULL
not	NULL
block	NULL
the	NULL
ligation	NULL
of	NULL
€CD27/	NULL
CD70	NULL
(	NULL
16	NULL
,	NULL
19	NULL
)	NULL
,	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
T.	NULL
Morimoto	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

FITC-conjugated	NULL
anti-CD20	NULL
mAb	NULL
and	NULL
PE-conju-gated	NULL
anti-CD20	NULL
mAb	NULL
were	NULL
purchased	NULL
from	NULL
Dako	NULL
Japan	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

FITC-conjugated	NULL
anti-CD38	NULL
mAb	NULL
(	NULL
T16	NULL
;	NULL
IgG1	NULL
)	NULL
,	NULL
anti-CD40	NULL
mAb	NULL
(	NULL
MAB89	NULL
;	NULL
IgG1	NULL
)	NULL
,	NULL
anti-CD70	NULL
mAb	NULL
(	NULL
HNES1	NULL
;	NULL
IgG1	NULL
)	NULL
,	NULL
and	NULL
anti-CD62L	NULL
mAb	NULL
(	NULL
TQ1	NULL
;	NULL
IgG1	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Immunotech	NULL
(	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
.	NULL

PE-conju-gated	NULL
anti-mouse	NULL
Ig	NULL
mAb	NULL
was	NULL
obtained	NULL
from	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
(	NULL
Birmingham	NULL
,	NULL
AL	NULL
)	NULL
.	NULL

Conjugation	NULL
of	NULL
biotin	NULL
to	NULL
anti-CD27	NULL
mAb	NULL
(	NULL
8H5	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
standard	NULL
technique	NULL
,	NULL
using	NULL
N-hydroxysuccin-imido-biotin	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

G418	NULL
was	NULL
purchased	NULL
from	NULL
Life	NULL
Technologies	NULL
(	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
human	NULL
IL-4	NULL
was	NULL
obtained	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
L	NULL
cell	NULL
line	NULL
expressing	NULL
murine	NULL
FeyII	NULL
receptor	NULL
(	NULL
CD32ZL	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

The	NULL
CD154-CD8	NULL
fusion	NULL
protein	NULL
(	NULL
cell	NULL
culture	NULL
supernatant	NULL
,	NULL
soluble	NULL
CD154	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Aruffo	NULL
(	NULL
Bristol-Myers/Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Cell	NULL
preparation	NULL
Adult	NULL
human	NULL
PBMNCs	NULL
were	NULL
isolated	NULL
from	NULL
healthy	NULL
volunteers	NULL
by	NULL
Ficoll-Hypague	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
density	NULL
gradient	NULL
centrifugation	NULL
and	NULL
2	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
PRDI-BF1	NULL
,	NULL
positive	NULL
regulatory	NULL
domain	NULL
I-binding	NULL
factor-1	NULL
;	NULL
BSAP	NULL
,	NULL
B	NULL
cell-specific	NULL
activator	NULL
protein	NULL
;	NULL
PE	NULL
,	NULL
phycoerythrin	NULL
;	NULL
E	NULL
,	NULL
erythrocyte	NULL
rosette-negative	NULL
;	NULL
SAC	NULL
,	NULL
Staphylococcus	NULL
aureus	NULL
Cowan	NULL
strain	NULL
;	NULL
Blimp-1	NULL
,	NULL
B	NULL
lymphocyte-induced	NULL
maturation	NULL
protein-1	NULL
.	NULL

0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
were	NULL
separated	NULL
with	NULL
5	NULL
%	NULL
sheep	NULL
erythrocytes	NULL
into	NULL
erythrocyte	NULL
rosette-posi-tive	NULL
and	NULL
-negative	NULL
(	NULL
E-	NULL
)	NULL
populations	NULL
(	NULL
20	NULL
)	NULL
.	NULL

After	NULL
depleting	NULL
monocytes	NULL
with	NULL
silica	NULL
(	NULL
IBL	NULL
,	NULL
Fujioka	NULL
,	NULL
Japan	NULL
)	NULL
or	NULL
by	NULL
adherence	NULL
to	NULL
the	NULL
plastic	NULL
surface	NULL
,	NULL
EC	NULL
cells	NULL
were	NULL
further	NULL
purified	NULL
into	NULL
B	NULL
cells	NULL
by	NULL
positive	NULL
selection	NULL
with	NULL
anti-CD19	NULL
mAb-coated	NULL
immunomagnetic	NULL
beads	NULL
(	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
,	NULL
and	NULL
then	NULL
anti-CD19	NULL
mAb	NULL
was	NULL
removed	NULL
by	NULL
the	NULL
use	NULL
of	NULL
Detach	NULL
a	NULL
Bead	NULL
(	NULL
Dynal	NULL
)	NULL
.	NULL

Ninety-seven	NULL
percent	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
population	NULL
was	NULL
reactive	NULL
with	NULL
anti-CD20	NULL
mAbs	NULL
.	NULL

Proliferation	NULL
and	NULL
activation	NULL
were	NULL
not	NULL
observed	NULL
from	NULL
the	NULL
B	NULL
cells	NULL
thus	NULL
ob-tained	NULL
.	NULL

CD20+*	NULL
CD27~	NULL
or	NULL
CD20®	NULL
CD27*	NULL
B	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
monocyte-depleted	NULL
E-	NULL
cells	NULL
by	NULL
sorting	NULL
with	NULL
a	NULL
FACStarPlus	NULL
(	NULL
Becton	NULL
Dick-inson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
under	NULL
sterile	NULL
conditions	NULL
.	NULL

Both	NULL
populations	NULL
obtained	NULL
were	NULL
>	NULL
98	NULL
%	NULL
pure	NULL
.	NULL

Preparation	NULL
of	NULL
transfectants	NULL
The	NULL
preparation	NULL
of	NULL
CD70	NULL
transfectants	NULL
or	NULL
mock	NULL
transfectants	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
single-step	NULL
method	NULL
(	NULL
21	NULL
)	NULL
from	NULL
the	NULL
CD70	NULL
+	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
Daudi	NULL
cells	NULL
)	NULL
.	NULL

After	NULL
RT-PCR	NULL
,	NULL
the	NULL
amplified	NULL
cDNA	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
Xbal	NULL
and	NULL
ligated	NULL
with	NULL
the	NULL
mammalian	NULL
expression	NULL
vector	NULL
peDLSR	NULL
@	NULL
296	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
plasmid	NULL
or	NULL
the	NULL
vector	NULL
alone	NULL
was	NULL
transfected	NULL
into	NULL
the	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
,	NULL
300-19	NULL
(	NULL
23	NULL
)	NULL
by	NULL
electroporation	NULL
.	NULL

The	NULL
transfectants	NULL
were	NULL
selected	NULL
by	NULL
growth	NULL
in	NULL
a	NULL
culture	NULL
medium	NULL
containing	NULL
a	NULL
neomycin	NULL
analogue	NULL
(	NULL
G418	NULL
,	NULL
Life	NULL
Technologies	NULL
)	NULL
at	NULL
1	NULL
mg/ml	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
Activated	NULL
purified	NULL
B	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
anti-CD38-FITC	NULL
and	NULL
anti-CD20-PE	NULL
.	NULL

Two-color	NULL
analysis	NULL
of	NULL
B	NULL
cell	NULL
surface	NULL
molecules	NULL
was	NULL
performed	NULL
by	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Ab-coated	NULL
cells	NULL
were	NULL
gated	NULL
on	NULL
living	NULL
cells	NULL
by	NULL
cell	NULL
size	NULL
and	NULL
granularity	NULL
,	NULL
and	NULL
dead	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
and	NULL
then	NULL
enumerated	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

Fixation	NULL
of	NULL
transfectant	NULL
cells	NULL
The	NULL
€CD70/300-19	NULL
or	NULL
mock/300-19	NULL
transfectants	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
for	NULL
5	NULL
min	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
PBS	NULL
three	NULL
times	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
used	NULL
for	NULL
the	NULL
analysis	NULL
.	NULL

Ig	NULL
assay	NULL
by	NULL
ELISA	NULL
Highly	NULL
purified	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
50	NULL
ng/ml	NULL
of	NULL
IL-4	NULL
and	NULL
1	NULL
pg/ml	NULL
of	NULL
anti-CD40	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
fixed	NULL
CD70/300-19	NULL
or	NULL
mock/300-19	NULL
with	NULL
or	NULL
without	NULL
1	NULL
pg/ml	NULL
of	NULL
anti-CD70	NULL
mAb	NULL
for	NULL
12-14	NULL
days	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

The	NULL
final	NULL
cell	NULL
density	NULL
was	NULL
5-10	NULL
X	NULL
10°/ml	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
200	NULL
pul/well	NULL
.	NULL

The	NULL
cultured	NULL
supernatants	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
and	NULL
the	NULL
standard	NULL
human	NULL
IgE	NULL
(	NULL
Chemicon	NULL
,	NULL
Temecula	NULL
,	NULL
CA	NULL
)	NULL
were	NULL
added	NULL
to	NULL
96-well	NULL
flat	NULL
ELISA	NULL
plates	NULL
(	NULL
Nunc	NULL
,	NULL
Roskilde	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
coated	NULL
with	NULL
human	NULL
IgE	NULL
mAbs	NULL
(	NULL
CIA-E-7.12	NULL
and	NULL
CIA-E-4.15	NULL
,	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Saxon	NULL
,	NULL
Division	NULL
of	NULL
Clinical	NULL
Immunology/Allergy	NULL
,	NULL
University	NULL
of	NULL
California	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

After	NULL
an	NULL
overnight	NULL
culture	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
supernatants	NULL
were	NULL
discarded	NULL
,	NULL
and	NULL
the	NULL
wells	NULL
were	NULL
washed	NULL
with	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
in	NULL
PBS	NULL
.	NULL

Alkaline	NULL
phosphatase-labeled	NULL
goat	NULL
anti-human	NULL
IgE	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1/5000	NULL
was	NULL
added	NULL
.	NULL

After	NULL
2	NULL
h	NULL
of	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
color	NULL
detection	NULL
was	NULL
performed	NULL
by	NULL
3-	NULL
[	NULL
cyclohexylamino	NULL
}	NULL
-1-propanesulfonic	NULL
acid	NULL
(	NULL
CAPS	NULL
)	NULL
buffer	NULL
containing	NULL
p-Nitrophenyl	NULL
phosphate	NULL
(	NULL
pNPP	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Calibration	NULL
was	NULL
performed	NULL
with	NULL
PBS	NULL
at	NULL
standard	NULL
zero	NULL
levels	NULL
.	NULL

The	NULL
limit	NULL
of	NULL
sensitivity	NULL
for	NULL
IgE	NULL
was	NULL
5	NULL
ng/ml	NULL
.	NULL

B	NULL
cell	NULL
proliferation	NULL
assay	NULL
Highly	NULL
purified	NULL
unseparated	NULL
B	NULL
cells	NULL
and	NULL
CD20*	NULL
CD27*	NULL
and	NULL
CD20*	NULL
CD27~	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
fixed	NULL
mock/300-19	NULL
or	NULL
€CD70/300-19	NULL
(	NULL
20	NULL
%	NULL
of	NULL
the	NULL
B	NULL
cells	NULL
added	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
ng/ml	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
1	NULL
ug/tal	NULL
anti-CD40	NULL
at	NULL
a	NULL
final	NULL
cell	NULL
density	NULL
of	NULL
2.5-5	NULL
X	NULL
10°/ml	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
200	NULL
pl/well	NULL
in	NULL
96-well	NULL
round-bottom	NULL
plates	NULL
(	NULL
Nunc	NULL
)	NULL
for	NULL
3	NULL
days	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Then	NULL
the	NULL
cultures	NULL
were	NULL
pulsed	NULL
with	NULL
0.5	NULL
uCi	NULL
of	NULL
[	NULL
*H	NULL
]	NULL
thymidine	NULL
.	NULL

After	NULL
18	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
with	NULL
an	NULL
automatic	NULL
cell	NULL
harvester	NULL
(	NULL
Packard	NULL
,	NULL
Meriden	NULL
,	NULL
CT	NULL
)	NULL
,	NULL
and	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
was	NULL
measured	NULL
on	NULL
a	NULL
liquid	NULL
scintillation	NULL
analyzer	NULL
(	NULL
Packard	NULL
)	NULL
.	NULL

RT-PCR	NULL
of	NULL
germline	NULL
e	NULL
,	NULL
BSAP	NULL
,	NULL
and	NULL
PRDI-BF1I	NULL
Highly	NULL
purified	NULL
unseparated	NULL
B	NULL
cells	NULL
and	NULL
€CD20+*	NULL
CD27*	NULL
or	NULL
CD20+*	NULL
CD27~	NULL
B	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
1	NULL
ug/tal	NULL
anti-€CD40	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mock	NULL
transfectants	NULL
or	NULL
CD70	NULL
transfectants	NULL
for	NULL
16	NULL
h	NULL
or	NULL
4	NULL
days	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
by	NULL
the	NULL
acid-guanidine	NULL
thiocyanate-phenol-chloroform	NULL
method	NULL
using	NULL
a	NULL
RNAzo	NULL
!	NULL

l	NULL
rapid	NULL
RNA	NULL
puri-	NULL
6497	NULL
fication	NULL
kit	NULL
(	NULL
Biotex	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

First-strand	NULL
cDNA	NULL
copies	NULL
were	NULL
synthesized	NULL
by	NULL
using	NULL
murine	NULL
Moloney	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
with	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
as	NULL
a	NULL
primer	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
,	NULL
and	NULL
then	NULL
PCR	NULL
was	NULL
performed	NULL
.	NULL

The	NULL
following	NULL
oligonucleotide	NULL
primers	NULL
were	NULL
used	NULL
for	NULL
PCR	NULL
:	NULL
for	NULL
Ce	NULL
exon	NULL
,	NULL
sense	NULL
primer	NULL
,	NULL
5-CATGCGGTCCACGACCAAGAC-3	NULL
'	NULL
;	NULL
antisense	NULL
primer	NULL
,	NULL
5'-CCACTGCACAGCTGGATGGAG-3	NULL
'	NULL
;	NULL
for	NULL
BSAP	NULL
,	NULL
5'-CAACCAAC	NULL
CAGTCCCAGCTTC-3	NULL
'	NULL
and	NULL
and	NULL
for	NULL
PRDI-BF1	NULL
,	NULL
5-AGCTGACAATGATGAATCTCA-3	NULL
'	NULL
and	NULL
5'-CT	NULL
TGGGGTAGTGAGCGTTGTA-3	NULL
'	NULL
.	NULL

Two	NULL
microliters	NULL
of	NULL
cDNA	NULL
were	NULL
amplified	NULL
in	NULL
PCR	NULL
using	NULL
each	NULL
primer	NULL
and	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Life	NULL
Tech-nologies	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
products	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
1.2	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
ethidium	NULL
bromide	NULL
and	NULL
visualized	NULL
by	NULL
UV	NULL
light	NULL
illumination	NULL
.	NULL

B	NULL
,	NULL
m	NULL
sense	NULL
primer	NULL
and	NULL
antisense	NULL
primer	NULL
5'-ATCTTCAAACCTCCATGATG-3	NULL
'	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Quantitative	NULL
RT-PCR	NULL
of	NULL
germline	NULL
Ce	NULL
In	NULL
the	NULL
germline	NULL
Ce	NULL
transcripts	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
mRNA	NULL
were	NULL
estimated	NULL
by	NULL
coamplification	NULL
of	NULL
parvo	NULL
virus	NULL
DNA	NULL
for	NULL
a	NULL
competitor	NULL
.	NULL

PCR	NULL
amplification	NULL
of	NULL
parvo	NULL
virus	NULL
DNA	NULL
,	NULL
which	NULL
includes	NULL
germline	NULL
Ce	NULL
primers	NULL
in	NULL
both	NULL
sides	NULL
,	NULL
was	NULL
conducted	NULL
with	NULL
flanking	NULL
primers	NULL
.	NULL

The	NULL
product	NULL
was	NULL
505	NULL
bp	NULL
in	NULL
length	NULL
and	NULL
was	NULL
separated	NULL
by	NULL
PAGE	NULL
and	NULL
purified	NULL
.	NULL

Each	NULL
template	NULL
contained	NULL
the	NULL
same	NULL
amounts	NULL
of	NULL
cDNA	NULL
from	NULL
RNA	NULL
extracted	NULL
from	NULL
highly	NULL
purified	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
one	NULL
of	NULL
fivefold	NULL
dilutions	NULL
of	NULL
germline	NULL
Ce	NULL
transcript	NULL
competitor	NULL
from	NULL
3.2	NULL
%	NULL
10~	NULL
'	NULL
to	NULL
2.6	NULL
X	NULL
10~°	NULL
attomoles	NULL
.	NULL

The	NULL
equivalent	NULL
point	NULL
was	NULL
determined	NULL
by	NULL
PAGE	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
amounts	NULL
of	NULL
germline	NULL
Ce	NULL
cDNA	NULL
in	NULL
the	NULL
samples	NULL
were	NULL
the	NULL
same	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
the	NULL
B-actin	NULL
cDNA	NULL
were	NULL
evaluated	NULL
as	NULL
an	NULL
internal	NULL
mRNA	NULL
control	NULL
.	NULL

Results	NULL
Augmentation	NULL
of	NULL
B	NULL
cell	NULL
IgE	NULL
.	NULL

production	NULL
by	NULL
CD27/CD70	NULL
interaction	NULL
Since	NULL
triggering	NULL
via	NULL
CD27	NULL
by	NULL
CD70	NULL
transfectants	NULL
,	NULL
which	NULL
greatly	NULL
express	NULL
CD70	NULL
on	NULL
the	NULL
surface	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
induces	NULL
IgA	NULL
,	NULL
IgM	NULL
,	NULL
and	NULL
IgG	NULL
synthesis	NULL
in	NULL
B	NULL
cell	NULL
activation	NULL
systems	NULL
with	NULL
SAC	NULL
plus	NULL
IL-2	NULL
(	NULL
15	NULL
)	NULL
and	NULL
IL-10	NULL
(	NULL
25	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
CD27/CD70	NULL
interaction	NULL
participates	NULL
in	NULL
B	NULL
cell	NULL
IgE	NULL
synthesis	NULL
.	NULL

To	NULL
clarify	NULL
the	NULL
direct	NULL
effect	NULL
of	NULL
CD27	NULL
signaling	NULL
on	NULL
IgE	NULL
synthesis	NULL
,	NULL
we	NULL
highly	NULL
purified	NULL
B	NULL
cells	NULL
from	NULL
adult	NULL
peripheral	NULL
blood	NULL
.	NULL

As	NULL
reported	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
,	NULL
anti-CD40	NULL
or	NULL
IL-4	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
IgE	NULL
synthesis	NULL
by	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD40	NULL
plus	NULL
IL-4	NULL
,	NULL
B	NULL
cells	NULL
produced	NULL
substantial	NULL
amounts	NULL
of	NULL
IgE	NULL
.	NULL

Most	NULL
significantly	NULL
,	NULL
CD70	NULL
transfectants	NULL
greatly	NULL
augmented	NULL
IgE	NULL
production	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
,	NULL
which	NULL
was	NULL
about	NULL
fourfold	NULL
compared	NULL
with	NULL
that	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
mock	NULL
transfectants	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
augmentation	NULL
of	NULL
IgE	NULL
synthesis	NULL
by	NULL
CD70	NULL
transfectants	NULL
was	NULL
dose	NULL
dependent	NULL
,	NULL
and	NULL
the	NULL
enhancement	NULL
of	NULL
IgE	NULL
production	NULL
by	NULL
CD70	NULL
transfectants	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
the	NULL
initial	NULL
addition	NULL
of	NULL
anti-CD70	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
control	NULL
mAb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
IL-4	NULL
or	NULL
anti-CD40	NULL
to	NULL
CD70	NULL
transfectants	NULL
did	NULL
not	NULL
induce	NULL
detectable	NULL
levels	NULL
of	NULL
IgE	NULL
secretion	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

When	NULL
we	NULL
stimulated	NULL
B	NULL
cells	NULL
by	NULL
cross-linking	NULL
with	NULL
anti-€CD40	NULL
plus	NULL
CD32	NULL
transfectants	NULL
and	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
soluble	NULL
€D154	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
,	NULL
IgE	NULL
production	NULL
was	NULL
32	NULL
+	NULL
7	NULL
and	NULL
21	NULL
+	NULL
5	NULL
ng/ml	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
triggering	NULL
via	NULL
CD27	NULL
by	NULL
its	NULL
ligand	NULL
,	NULL
CD70	NULL
,	NULL
synergistically	NULL
induces	NULL
B	NULL
cell	NULL
IgE	NULL
synthesis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
€D27/CD70	NULL
interaction	NULL
is	NULL
involved	NULL
in	NULL
B	NULL
cell	NULL
IgE	NULL
synthesis	NULL
by	NULL
direct	NULL
cell	NULL
to	NULL
cell	NULL
contact	NULL
.	NULL

Production	NULL
of	NULL
IgE	NULL
by	NULL
CD27	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
by	NULL
CD27	NULL
B	NULL
cells	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
Having	NULL
demonstrated	NULL
that	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
can	NULL
be	NULL
separated	NULL
by	NULL
CD27	NULL
expression	NULL
,	NULL
and	NULL
that	NULL
CD27	NULL
*	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
CD27~	NULL
B	NULL
cells	NULL
,	NULL
produce	NULL
large	NULL
amounts	NULL
of	NULL
IgA	NULL
,	NULL
IgM	NULL
,	NULL
and	NULL
IgG	NULL
(	NULL
27	NULL
)	NULL
,	NULL
we	NULL
conducted	NULL
additional	NULL
experiments	NULL
to	NULL
determine	NULL
whether	NULL
B	NULL
cell	NULL
subpopulations	NULL
separated	NULL
by	NULL
CD27	NULL
have	NULL
different	NULL
functions	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
IgE	NULL
synthesis	NULL
.	NULL

We	NULL
purified	NULL
CD20*	NULL
CD27*	NULL
B	NULL
cells	NULL
and	NULL
CD20*CD27~	NULL
B	NULL
cells	NULL
by	NULL
flow	NULL
cytometry	NULL
;	NULL
the	NULL
purities	NULL
of	NULL
the	NULL
two	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6498	NULL
A	NULL
Mock	NULL
trans	NULL
.	NULL

CD70	NULL
trans	NULL
.	NULL

tz	NULL
120	NULL
.	NULL

iso	NULL
so	NULL
so	NULL
C	NULL
I	NULL
a	NULL
«	NULL
]	NULL
/	NULL
\	NULL
s	NULL
#	NULL
I	NULL
``	NULL
T	NULL
CP	NULL
T	NULL
&	NULL
_	NULL
_	NULL
I	NULL
CD70-PE	NULL
CD70-PE	NULL
x	NULL
[	NULL
F	NULL
37	NULL
iy	NULL
|	NULL
i	NULL
i	NULL
Medium	NULL
IL-4	NULL
+	NULL
CD70-trans	NULL
,	NULL
(	NULL
20	NULL
%	NULL
)	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
40	NULL
%	NULL
)	NULL
Anti-CD40	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
20	NULL
%	NULL
)	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
40	NULL
%	NULL
)	NULL
IL-4	NULL
+	NULL
anti-CD40	NULL
+	NULL
mock-trans	NULL
.	NULL

(	NULL
20	NULL
%	NULL
)	NULL
+	NULL
mock-trans	NULL
.	NULL

(	NULL
40	NULL
%	NULL
)	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
20	NULL
%	NULL
)	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
40	NULL
%	NULL
)	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
20	NULL
%	NULL
)	NULL
+	NULL
anti-CD70	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
40	NULL
%	NULL
)	NULL
+	NULL
anti-CD70	NULL
0	NULL
so	NULL
100	NULL
IgE	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

FIGURE	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
CD70	NULL
by	NULL
mock	NULL
and	NULL
CD70	NULL
transfectants	NULL
and	NULL
enhancement	NULL
of	NULL
B	NULL
cell	NULL
IgE	NULL
synthesis	NULL
by	NULL
CD27/CD70	NULL
interaction	NULL
.	NULL

A	NULL
,	NULL
Mock	NULL
and	NULL
CD70	NULL
transfectants	NULL
were	NULL
stained	NULL
with	NULL
mouse	NULL
anti-human	NULL
CD70	NULL
mAb	NULL
(	NULL
HNES1	NULL
)	NULL
followed	NULL
by	NULL
(	NULL
goat	NULL
)	NULL
anti-mouse	NULL
Ig-PE	NULL
.	NULL

Expression	NULL
of	NULL
CD70	NULL
on	NULL
mock	NULL
and	NULL
CD70	NULL
transfectants	NULL
is	NULL
shown	NULL
with	NULL
a	NULL
log	NULL
scale	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
.	NULL

Iso-type-matched	NULL
PE-labeled	NULL
mAb	NULL
was	NULL
used	NULL
as	NULL
the	NULL
negative	NULL
control	NULL
(	NULL
dotted	NULL
line	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Highly	NULL
purified	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
medium	NULL
,	NULL
IL-4	NULL
,	NULL
anti-CD40	NULL
,	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mock	NULL
transfectants	NULL
or	NULL
CD70	NULL
transfectants	NULL
with	NULL
or	NULL
without	NULL
anti-CD70	NULL
mAb	NULL
at	NULL
a	NULL
final	NULL
cell	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10	NULL
``	NULL
/well	NULL
in	NULL
96-well	NULL
round-bottom	NULL
plates	NULL
for	NULL
12-14	NULL
days	NULL
.	NULL

IgE	NULL
content	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
deter-minations	NULL
,	NULL
and	NULL
error	NULL
bars	NULL
are	NULL
sometimes	NULL
smaller	NULL
than	NULL
the	NULL
plot	NULL
symbol	NULL
.	NULL

cell	NULL
populations	NULL
were	NULL
>	NULL
98	NULL
%	NULL
.	NULL

CD27*	NULL
B	NULL
cells	NULL
produced	NULL
IgE	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
anti-CD40	NULL
alone	NULL
.	NULL

The	NULL
production	NULL
of	NULL
IgE	NULL
by	NULL
CD27*	NULL
B	NULL
cells	NULL
was	NULL
strongly	NULL
enhanced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
CD70	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
,	NULL
whereas	NULL
mock	NULL
transfectants	NULL
did	NULL
not	NULL
have	NULL
such	NULL
an	NULL
enhancing	NULL
effect	NULL
.	NULL

The	NULL
enhancement	NULL
by	NULL
the	NULL
CD70	NULL
transfectants	NULL
was	NULL
specifically	NULL
blocked	NULL
by	NULL
the	NULL
initial	NULL
addition	NULL
of	NULL
anti-CD70	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
IgE	NULL
secretion	NULL
from	NULL
CD27	NULL
~	NULL
B	NULL
cells	NULL
was	NULL
below	NULL
measurable	NULL
levels	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
,	NULL
even	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
CD70	NULL
transfectants	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
CD27*	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
CD27~	NULL
B	NULL
cells	NULL
,	NULL
have	NULL
ability	NULL
to	NULL
produce	NULL
IgE	NULL
and	NULL
that	NULL
signaling	NULL
via	NULL
the	NULL
CD27	NULL
molecule	NULL
participates	NULL
in	NULL
the	NULL
IgE	NULL
synthesis	NULL
.	NULL

B	NULL
cell	NULL
proliferation	NULL
by	NULL
CD27/CD70	NULL
ligation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
We	NULL
next	NULL
investigated	NULL
whether	NULL
CD27	NULL
molecule	NULL
on	NULL
B	NULL
cells	NULL
contributed	NULL
to	NULL
their	NULL
proliferation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
.	NULL

IL-4	NULL
alone	NULL
induced	NULL
low	NULL
levels	NULL
of	NULL
proliferation	NULL
of	NULL
unseparated	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
B	NULL
cell	NULL
proliferation	NULL
was	NULL
enhanced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
anti-CD40	NULL
to	NULL
IL-4	NULL
compared	NULL
with	NULL
that	NULL
with	NULL
IL-4	NULL
alone	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
proliferation	NULL
of	NULL
B	NULL
cells	NULL
was	NULL
augmented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
CD70	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
,	NULL
whereas	NULL
mock	NULL
transfectants	NULL
did	NULL
not	NULL
have	NULL
such	NULL
an	NULL
en-	NULL
AUGMENTATION	NULL
OF	NULL
IgE	NULL
SYNTHESIS	NULL
BY	NULL
CD27/CD70	NULL
CD27	NULL
*	NULL
B	NULL
cells	NULL
CD27	NULL
~	NULL
B	NULL
cells	NULL
Medium	NULL
TL-4	NULL
+	NULL
anti-CD40	NULL
+	NULL
mock-trans	NULL
.	NULL

(	NULL
20	NULL
%	NULL
)	NULL
+	NULL
mock-trans	NULL
.	NULL

(	NULL
40	NULL
%	NULL
)	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
20	NULL
%	NULL
)	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
40	NULL
%	NULL
)	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
20	NULL
%	NULL
)	NULL
+	NULL
anti-CD70	NULL
+	NULL
CD70-trans	NULL
.	NULL

(	NULL
40	NULL
%	NULL
)	NULL
+	NULL
anti-CD70	NULL
o	NULL
so	NULL
100	NULL
0	NULL
so	NULL
100	NULL
IgE	NULL
(	NULL
ng/ml	NULL
)	NULL
IgE	NULL
(	NULL
ng/mD	NULL
FIGURE	NULL
2	NULL
.	NULL

Production	NULL
of	NULL
IgE	NULL
in	NULL
CD27*	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
CD27~	NULL
B	NULL
cells	NULL
.	NULL

CD20+*	NULL
CD27*	NULL
B	NULL
cells	NULL
and	NULL
CD20+*	NULL
CD27~	NULL
B	NULL
cells	NULL
were	NULL
separated	NULL
from	NULL
adult	NULL
peripheral	NULL
blood	NULL
EC	NULL
cells	NULL
by	NULL
means	NULL
of	NULL
flow	NULL
cytometry	NULL
(	NULL
purity	NULL
was	NULL
>	NULL
97	NULL
%	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
highly	NULL
purified	NULL
CD27*	NULL
and	NULL
CD27~	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mock	NULL
transfectants	NULL
or	NULL
CD70	NULL
transfectants	NULL
with	NULL
or	NULL
without	NULL
anti-CD70	NULL
mAb	NULL
at	NULL
a	NULL
final	NULL
cell	NULL
density	NULL
of	NULL
0.5	NULL
X	NULL
10°/well	NULL
for	NULL
12-14	NULL
days	NULL
.	NULL

IgE	NULL
content	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
.	NULL

The	NULL
data	NULL
were	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
determinations	NULL
.	NULL

hancing	NULL
effect	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
augmentation	NULL
of	NULL
B	NULL
cell	NULL
proliferation	NULL
by	NULL
CD70	NULL
transfectants	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
the	NULL
initial	NULL
addition	NULL
of	NULL
anti-CD70	NULL
mAb	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

B	NULL
cell	NULL
proliferation	NULL
was	NULL
greatly	NULL
increased	NULL
by	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
plus	NULL
CD32	NULL
transfectants	NULL
(	NULL
18,952	NULL
+	NULL
2,802	NULL
cpm	NULL
;	NULL
n	NULL
=	NULL
3	NULL
)	NULL
or	NULL
IL-4	NULL
plus	NULL
soluble	NULL
€CD154	NULL
(	NULL
15,916	NULL
+	NULL
2,156	NULL
cpm	NULL
;	NULL
n	NULL
=	NULL
3	NULL
)	NULL
compared	NULL
with	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
stimulation	NULL
(	NULL
2,409	NULL
+	NULL
1,067	NULL
cpm	NULL
;	NULL
n	NULL
=	NULL
7	NULL
)	NULL
.	NULL

As	NULL
the	NULL
baseline	NULL
levels	NULL
of	NULL
B	NULL
cell	NULL
proliferation	NULL
were	NULL
high	NULL
in	NULL
these	NULL
systems	NULL
with	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
plus	NULL
CD32	NULL
transfectants	NULL
or	NULL
IL-4	NULL
plus	NULL
soluble	NULL
CD154	NULL
only	NULL
,	NULL
the	NULL
enhancing	NULL
effects	NULL
of	NULL
CD70	NULL
transfectants	NULL
on	NULL
B	NULL
cell	NULL
proliferation	NULL
were	NULL
not	NULL
prominent	NULL
:	NULL
the	NULL
values	NULL
with	NULL
CD70	NULL
transfectants	NULL
were	NULL
21,304	NULL
+	NULL
4,012	NULL
cpm	NULL
(	NULL
r	NULL
=	NULL
3	NULL
)	NULL
in	NULL
the	NULL
former	NULL
and	NULL
19,185	NULL
+	NULL
3,231	NULL
cpm	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
in	NULL
the	NULL
latter	NULL
system	NULL
.	NULL

This	NULL
enhancement	NULL
of	NULL
B	NULL
cell	NULL
proliferation	NULL
by	NULL
CD70	NULL
transfectants	NULL
was	NULL
obtained	NULL
in	NULL
CD27*	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
was	NULL
very	NULL
mild	NULL
in	NULL
CD27	NULL
B	NULL
cells	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
Table	NULL
I	NULL
.	NULL

B	NULL
cell	NULL
proliferation	NULL
by	NULL
CD70	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
mAb	NULL
°H	NULL
]	NULL
Thymidine	NULL
Incorporation	NULL
``	NULL
Expt	NULL
.	NULL

1	NULL
Expt	NULL
.	NULL

2	NULL
Medium	NULL
239	NULL
+	NULL
52°	NULL
322	NULL
+	NULL
73	NULL
IL-4°	NULL
356	NULL
+	NULL
80	NULL
723	NULL
+	NULL
175	NULL
+	NULL
mock-trans	NULL
.	NULL
``	NULL

387	NULL
+	NULL
78	NULL
572	NULL
+	NULL
101	NULL
+	NULL
CD70-trans	NULL
.	NULL
``	NULL

1227	NULL
+	NULL
315	NULL
1389	NULL
+	NULL
216	NULL
+	NULL
CD70-trans	NULL
.	NULL

+	NULL
HNES1®	NULL
365	NULL
+	NULL
81	NULL
654	NULL
+	NULL
155	NULL
+	NULL
CD70-trans	NULL
.	NULL

+	NULL
TQI®	NULL
1305	NULL
+	NULL
322	NULL
1443	NULL
+	NULL
319	NULL
IL-4	NULL
+	NULL
anti-CD40®	NULL
1161	NULL
+	NULL
216	NULL
2949	NULL
+	NULL
465	NULL
+	NULL
mock-trans	NULL
.	NULL

1396	NULL
+	NULL
329	NULL
2820	NULL
+	NULL
498	NULL
+CD70-trans	NULL
.	NULL

2193	NULL
+	NULL
476	NULL
8174	NULL
+	NULL
1,279	NULL
+CD70-trans	NULL
.	NULL

+	NULL
HNESL	NULL
1185	NULL
+	NULL
237	NULL
3066	NULL
+	NULL
793	NULL
+	NULL
CD70-trans	NULL
.	NULL

+	NULL
2218	NULL
+	NULL
531	NULL
7792	NULL
+	NULL
1378	NULL
``	NULL
Proliferation	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
5	NULL
X	NULL
10*/well	NULL
of	NULL
highly	NULL
purified	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
.	NULL

*	NULL
Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicates	NULL
.	NULL

©	NULL
The	NULL
final	NULL
concentration	NULL
of	NULL
IL-4	NULL
and	NULL
anti-CD40	NULL
mAb	NULL
was	NULL
50	NULL
ng/ml	NULL
and	NULL
1	NULL
pg/ml	NULL
,	NULL
respectively	NULL
.	NULL

``	NULL
The	NULL
transfectants	NULL
were	NULL
present	NULL
as	NULL
20	NULL
%	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
numbers	NULL
added	NULL
.	NULL

®	NULL
Both	NULL
Abs	NULL
were	NULL
added	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
pg/ml	NULL
at	NULL
the	NULL
initiation	NULL
of	NULL
cell	NULL
culture	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Table	NULL
II	NULL
.	NULL

CD27*	NULL
and	NULL
CD27	NULL
B	NULL
cell	NULL
proliferation	NULL
by	NULL
CD70	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
mAb	NULL
[	NULL
°H	NULL
]	NULL
Thymidine	NULL
Incorporation	NULL
``	NULL
CD27*	NULL
B	NULL
cells	NULL
CD27~	NULL
B	NULL
cells	NULL
IL-4*	NULL
+	NULL
mock-trans.©	NULL
537	NULL
+	NULL
1424	NULL
_	NULL
781	NULL
+180	NULL
IL-4	NULL
+	NULL
CD7O0-trans	NULL
.	NULL
``	NULL

1511	NULL
+325	NULL
_	NULL
1023	NULL
+	NULL
293	NULL
IL-4	NULL
+	NULL
anti-CD40	NULL
``	NULL
+	NULL
mock-trans	NULL
.	NULL

1101	NULL
+	NULL
291	NULL
889	NULL
+	NULL
283	NULL
IL-4	NULL
+	NULL
anti-CD40	NULL
+	NULL
CD70-trans	NULL
.	NULL

-	NULL
2054	NULL
+	NULL
446	NULL
_	NULL
1240	NULL
+	NULL
305	NULL
``	NULL
Proliferation	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
3	NULL
X	NULL
10*/well	NULL
of	NULL
CD27*	NULL
or	NULL
CD27~	NULL
B	NULL
cells	NULL
.	NULL

*	NULL
The	NULL
final	NULL
concentration	NULL
of	NULL
IL-4	NULL
and	NULL
anti-CD40	NULL
mAb	NULL
was	NULL
50	NULL
ng/ml	NULL
and	NULL
1	NULL
pg/ml	NULL
,	NULL
respectively	NULL
.	NULL

©	NULL
The	NULL
transfectants	NULL
were	NULL
present	NULL
as	NULL
20	NULL
%	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
numbers	NULL
added	NULL
.	NULL

``	NULL
Results	NULL
are	NULL
expressed	NULL
at	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicates	NULL
.	NULL

results	NULL
suggest	NULL
that	NULL
the	NULL
ligation	NULL
of	NULL
CD27	NULL
on	NULL
B	NULL
cells	NULL
by	NULL
CD70	NULL
transfectants	NULL
enhances	NULL
B	NULL
cell	NULL
proliferation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
.	NULL

CD27	NULL
signaling	NULL
in	NULL
B	NULL
cells	NULL
does	NULL
not	NULL
enhance	NULL
germline	NULL
e	NULL
transcripts	NULL
Since	NULL
B	NULL
cell	NULL
IgE	NULL
production	NULL
was	NULL
strongly	NULL
enhanced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
CD70	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
expression	NULL
of	NULL
germline	NULL
e	NULL
transcripts	NULL
,	NULL
which	NULL
is	NULL
an	NULL
early	NULL
molecular	NULL
markers	NULL
of	NULL
the	NULL
isotype	NULL
switch	NULL
process	NULL
,	NULL
to	NULL
examine	NULL
possible	NULL
early	NULL
switch	NULL
events	NULL
being	NULL
induced	NULL
by	NULL
CD70	NULL
transfectants	NULL
.	NULL

Germline	NULL
e	NULL
transcripts	NULL
from	NULL
highly	NULL
purified	NULL
B	NULL
cells	NULL
were	NULL
not	NULL
obtained	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
medium	NULL
,	NULL
CD70	NULL
transfectants	NULL
,	NULL
or	NULL
anti-CD40	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Representative	NULL
data	NULL
by	NULL
quantitative	NULL
RT-PCR	NULL
showed	NULL
that	NULL
germline	NULL
e	NULL
transcripts	NULL
were	NULL
induced	NULL
by	NULL
IL-4	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
,	NULL
the	NULL
transcript	NULL
expression	NULL
by	NULL
B	NULL
cells	NULL
was	NULL
not	NULL
enhanced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
anti-CD40	NULL
to	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

We	NULL
were	NULL
unable	NULL
to	NULL
find	NULL
differences	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
germline	NULL
e	NULL
by	NULL
B	NULL
cells	NULL
in	NULL
CD70	NULL
transfectant-treated	NULL
vs	NULL
untreated	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
CD70	NULL
transfectants	NULL
also	NULL
had	NULL
no	NULL
enhancing	NULL
effect	NULL
on	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
plus	NULL
CD32	NULL
transfectants	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
did	NULL
not	NULL
change	NULL
with	NULL
various	NULL
culture	NULL
times	NULL
from	NULL
16-48	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
CD27~	NULL
B	NULL
cells	NULL
did	NULL
not	NULL
produce	NULL
IgE	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
their	NULL
germline	NULL
e	NULL
transcripts	NULL
were	NULL
obtained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
increased	NULL
IgE	NULL
secretion	NULL
from	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
by	NULL
CD27/	NULL
CD70	NULL
interaction	NULL
does	NULL
not	NULL
occur	NULL
in	NULL
the	NULL
process	NULL
of	NULL
germline	NULL
e	NULL
transcripts	NULL
.	NULL

Induction	NULL
of	NULL
plasma	NULL
cells	NULL
by	NULL
CD27/CD70	NULL
interaction	NULL
with	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
Recently	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
triggering	NULL
via	NULL
CD27	NULL
by	NULL
CD70	NULL
on	NULL
purified	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
yielded	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
plasma	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-10	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
prompted	NULL
us	NULL
to	NULL
ascertain	NULL
whether	NULL
CD27/CD70	NULL
interaction	NULL
induced	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
into	NULL
plasma	NULL
cells	NULL
secreting	NULL
IgE	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
CD27	NULL
signaling	NULL
on	NULL
peripheral	NULL
blood	NULL
B	NULL
cell	NULL
differentiation	NULL
stimulated	NULL
with	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
by	NULL
flow	NULL
cytometric	NULL
and	NULL
morphological	NULL
anal-yses	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
CD20	NULL
and	NULL
CD40	NULL
and	NULL
a	NULL
low	NULL
level	NULL
of	NULL
CD38	NULL
,	NULL
and	NULL
plasma	NULL
cells	NULL
expressed	NULL
CD38	NULL
strongly	NULL
.	NULL

Most	NULL
interestingly	NULL
,	NULL
B	NULL
cells	NULL
stimulated	NULL
with	NULL
CD70	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
for	NULL
12-14	NULL
days	NULL
differentiated	NULL
into	NULL
plasma	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
without	NULL
CD27	NULL
signaling	NULL
induced	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
plasma	NULL
cells	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
the	NULL
differentiation	NULL
from	NULL
B	NULL
cells	NULL
to	NULL
plasma	NULL
cells	NULL
disappeared	NULL
by	NULL
the	NULL
blockage	NULL
between	NULL
CD27	NULL
6499	NULL
Cs	NULL
B-actin	NULL
1/5	NULL
1/25	NULL
1/125	NULL
IL-4	NULL
1	NULL
1/5	NULL
wasi/ies	NULL
_	NULL
1	NULL
no	NULL
trans	NULL
.	NULL

+	NULL
CD70	NULL
trans	NULL
.	NULL

IL-4	NULL
+	NULL
anti-CD40	NULL
no	NULL
trans	NULL
.	NULL

T712	NULL
bp	NULL
C289	NULL
bp	NULL
FIGURE	NULL
3	NULL
.	NULL

CD27	NULL
signaling	NULL
in	NULL
B	NULL
cells	NULL
does	NULL
not	NULL
enhance	NULL
germline	NULL
e	NULL
transcript	NULL
expression	NULL
.	NULL

The	NULL
highly	NULL
purified	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
for	NULL
16	NULL
h.	NULL
After	NULL
extraction	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
quantitative	NULL
RT-PCR	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Each	NULL
template	NULL
contained	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
cDNA	NULL
from	NULL
RNA	NULL
extracted	NULL
from	NULL
1	NULL
X	NULL
10°	NULL
highly	NULL
purified	NULL
B	NULL
cells	NULL
and	NULL
one	NULL
of	NULL
fivefold	NULL
dilutions	NULL
of	NULL
germline	NULL
Ce	NULL
transcript	NULL
competitor	NULL
from	NULL
3.2	NULL
X	NULL
10~	NULL
'	NULL
to	NULL
2.6	NULL
X	NULL
10°	NULL
``	NULL
attomoles	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
the	NULL
germline	NULL
Ce	NULL
mRNA	NULL
were	NULL
quantitated	NULL
by	NULL
the	NULL
amounts	NULL
of	NULL
the	NULL
competitive	NULL
template	NULL
that	NULL
most	NULL
nearly	NULL
equaled	NULL
the	NULL
amplification	NULL
of	NULL
the	NULL
cellular	NULL
cDNA	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

T	NULL
,	NULL
target	NULL
cDNA	NULL
products	NULL
;	NULL
C	NULL
,	NULL
competitive	NULL
products	NULL
.	NULL

The	NULL
competitive	NULL
PCR	NULL
assay	NULL
of	NULL
the	NULL
B-actin	NULL
in	NULL
the	NULL
same	NULL
samples	NULL
is	NULL
shown	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
amounts	NULL
of	NULL
cDNA	NULL
used	NULL
for	NULL
the	NULL
assay	NULL
were	NULL
the	NULL
same	NULL
.	NULL

The	NULL
fractions	NULL
above	NULL
represent	NULL
the	NULL
dilution	NULL
series	NULL
of	NULL
the	NULL
competitive	NULL
Ce	NULL
DNA	NULL
and	NULL
the	NULL
competitive	NULL
B-actin	NULL
DNA	NULL
(	NULL
1	NULL
corresponds	NULL
to	NULL
3.2	NULL
X	NULL
10~	NULL
'	NULL
attomoles	NULL
)	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
five	NULL
separate	NULL
experiments	NULL
.	NULL

and	NULL
CD70	NULL
interaction	NULL
with	NULL
anti-CD70	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Morphological	NULL
analysis	NULL
showed	NULL
that	NULL
CD20~	NULL
CD38	NULL
``	NULL
®	NULL
``	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
increased	NULL
by	NULL
CD27/CD70	NULL
interaction	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
Ce	NULL
B-actin	NULL
1	NULL
1/51/25	NULL
17/125	NULL
1	NULL
1/5	NULL
1/25	NULL
1/125	NULL
1	NULL
1	NULL
C	NULL
505	NULL
bp	NULL
T	NULL
712	NULL
bp	NULL
F	NULL
CD27	NULL
~	NULL
B	NULL
cells	NULL
%	NULL
T	NULL
T	NULL
407	NULL
bp	NULL
1	NULL
C	NULL
289	NULL
bp	NULL
FIGURE	NULL
4	NULL
.	NULL

Germline	NULL
e	NULL
transcript	NULL
expression	NULL
by	NULL
CD27*	NULL
B	NULL
cells	NULL
and	NULL
CD27~	NULL
B	NULL
cells	NULL
.	NULL

CD27*	NULL
and	NULL
CD27~	NULL
B	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
for	NULL
16	NULL
h.	NULL
After	NULL
extraction	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
quantitative	NULL
RT-PCR	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Each	NULL
template	NULL
contained	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
cDNA	NULL
from	NULL
RNA	NULL
extracted	NULL
from	NULL
1	NULL
X	NULL
10°	NULL
highly	NULL
purified	NULL
B	NULL
cells	NULL
and	NULL
one	NULL
of	NULL
fivefold	NULL
dilutions	NULL
of	NULL
germline	NULL
Ce	NULL
transcript	NULL
competitor	NULL
from	NULL
3.2	NULL
X	NULL
10~	NULL
'	NULL
to	NULL
2.6	NULL
X	NULL
10~°	NULL
attomoles	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6500	NULL
A	NULL
IL-4	NULL
+	NULL
anti-CD40	NULL
+	NULL
mock-trans	NULL
.	NULL

AUGMENTATION	NULL
OF	NULL
IgE	NULL
SYNTHESIS	NULL
BY	NULL
CD27/CD70	NULL
IL-4	NULL
+	NULL
anti-CD40	NULL
+	NULL
CD7O0-trans	NULL
.	NULL

+	NULL
HNE51	NULL
IL-4	NULL
+	NULL
anti-0CD40	NULL
+	NULL
CD7O0-trans	NULL
.	NULL

156	NULL
%	NULL
FIGURE	NULL
5	NULL
.	NULL

Induction	NULL
of	NULL
plasma	NULL
cells	NULL
by	NULL
triggering	NULL
via	NULL
CD27	NULL
on	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
mAb	NULL
.	NULL

A	NULL
,	NULL
Highly	NULL
purified	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
IL-4	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
plus	NULL
anti-CD40	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mock	NULL
transfectants	NULL
,	NULL
CD70	NULL
transfectants	NULL
,	NULL
or	NULL
CD70	NULL
transfectants	NULL
plus	NULL
anti-CD70	NULL
mAb	NULL
(	NULL
1	NULL
ug/tal	NULL
)	NULL
for	NULL
12-14	NULL
days	NULL
.	NULL

Then	NULL
the	NULL
cells	NULL
were	NULL
t	NULL
}	NULL
:	NULL
CD20-PE	NULL
146	NULL
%	NULL
v	NULL
4156	NULL
4	NULL
%	NULL
~	NULL
6	NULL
%	NULL
stained	NULL
with	NULL
anti-CD38-FITC	NULL
and	NULL
anti-CD20-	NULL
&	NULL
PE	NULL
.	NULL

Ab-coated	NULL
cells	NULL
were	NULL
gated	NULL
on	NULL
living	NULL
cells	NULL
by	NULL
cell	NULL
size	NULL
and	NULL
granularity	NULL
,	NULL
and	NULL
dead	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
propidium	NULL
iodide	NULL
(	NULL
PT	NULL
)	NULL
staining	NULL
and	NULL
then	NULL
enumerated	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

Expressions	NULL
of	NULL
CD38	NULL
and	NULL
CD20	NULL
on	NULL
B	NULL
B	NULL
cells	NULL
are	NULL
shown	NULL
with	NULL
a	NULL
log	NULL
scale	NULL
.	NULL

B	NULL
,	NULL
Highly	NULL
pu	NULL
CDO38-FITC	NULL
To	NULL
The	NULL
Si	NULL
Th	NULL
i	NULL
CDO38-FITC	NULL
rified	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
plus	NULL
CD70	NULL
transfectants	NULL
for	NULL
14	NULL
days	NULL
.	NULL

Then	NULL
the	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
CD38~	NULL
CD20*	NULL
B	NULL
cells	NULL
(	NULL
a	NULL
)	NULL
and	NULL
CD38*	NULL
CD20~	NULL
plasma	NULL
cells	NULL
(	NULL
b	NULL
)	NULL
by	NULL
sorting	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cy-tospun	NULL
and	NULL
stained	NULL
with	NULL
May-Giemsa	NULL
staining	NULL
.	NULL

CD20-PE	NULL
CD38-FITC	NULL
anti-CD40	NULL
,	NULL
were	NULL
typical	NULL
plasma	NULL
cells	NULL
with	NULL
a	NULL
basophilic	NULL
cytoplasm	NULL
with	NULL
a	NULL
pale	NULL
Golgi	NULL
zone	NULL
and	NULL
an	NULL
eccentric	NULL
nucleus	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD20*	NULL
CD38	NULL
``	NULL
cells	NULL
revealed	NULL
the	NULL
morphology	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
demonstrated	NULL
that	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
IgE	NULL
production	NULL
measurement	NULL
,	NULL
CD27/CD70	NULL
interaction	NULL
promotes	NULL
plasma	NULL
cell	NULL
differentiation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
.	NULL

Effect	NULL
of	NULL
CD27/CD70	NULL
interaction	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
PRDI-BF1	NULL
and	NULL
BSAP	NULL
As	NULL
a	NULL
further	NULL
assessment	NULL
of	NULL
the	NULL
role	NULL
of	NULL
CD27	NULL
signaling	NULL
on	NULL
B	NULL
cell	NULL
differentiation	NULL
into	NULL
plasma	NULL
cells	NULL
,	NULL
we	NULL
finally	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
CD27/CD70	NULL
interaction	NULL
on	NULL
the	NULL
mRNA	NULL
expression	NULL
of	NULL
PRDI-	NULL
lad	NULL
-+	NULL
PRDI-BF1	NULL
594	NULL
bp	NULL
467	NULL
bp	NULL
-=-	NULL
B2-MG	NULL
20+	NULL
251	NULL
bp	NULL
FIGURE	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
CD27	NULL
cross-linking	NULL
on	NULL
PRDI-BF1	NULL
and	NULL
BSAP	NULL
expression	NULL
.	NULL

Mock	NULL
transfectants	NULL
alone	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
CD70	NULL
transfectants	NULL
alone	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
highly	NULL
purified	NULL
B	NULL
cells	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
mock	NULL
transfectants	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
,	NULL
or	NULL
CD70	NULL
transfectants	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
8	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
for	NULL
16	NULL
h	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
or	NULL
4	NULL
days	NULL
(	NULL
lanes	NULL
6-8	NULL
)	NULL
.	NULL

After	NULL
extraction	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
RT-PCR	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
1-kb	NULL
ladder	NULL
was	NULL
used	NULL
as	NULL
a	NULL
m.w	NULL
.	NULL

marker	NULL
(	NULL
M	NULL
)	NULL
.	NULL

The	NULL
C	NULL
lanes	NULL
represent	NULL
control	NULL
of	NULL
contamination-free	NULL
reaction	NULL
,	NULL
in	NULL
which	NULL
all	NULL
PCR	NULL
reagents	NULL
are	NULL
present	NULL
,	NULL
but	NULL
there	NULL
is	NULL
no	NULL
cDNA	NULL
.	NULL

B	NULL
,	NULL
m	NULL
(	NULL
B	NULL
,	NULL
-MG	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
the	NULL
results	NULL
of	NULL
three	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

BF1/Blimp-1	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
multiple	NULL
steps	NULL
of	NULL
B	NULL
cell	NULL
differentiation	NULL
leading	NULL
to	NULL
plasma	NULL
cell	NULL
development	NULL
(	NULL
28	NULL
)	NULL
and	NULL
the	NULL
transcription	NULL
factor	NULL
BSAP	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
PRDI-BFI	NULL
mRNA	NULL
expression	NULL
was	NULL
up-regulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
CD70	NULL
transfectants	NULL
compared	NULL
with	NULL
that	NULL
with	NULL
mock	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
after	NULL
both	NULL
16	NULL
h	NULL
and	NULL
4	NULL
days	NULL
of	NULL
culture	NULL
.	NULL

Up-regulation	NULL
of	NULL
BSAP	NULL
mRNA	NULL
expression	NULL
was	NULL
observed	NULL
,	NULL
although	NULL
it	NULL
was	NULL
not	NULL
significant	NULL
,	NULL
in	NULL
CD70	NULL
transfectant-treated	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
.	NULL

The	NULL
enhancement	NULL
of	NULL
PRDI-BF1	NULL
and	NULL
BSAP	NULL
mRNA	NULL
levels	NULL
by	NULL
CD70	NULL
transfectants	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
the	NULL
initial	NULL
addition	NULL
of	NULL
anti-CD70	NULL
blocking	NULL
mAb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
murine	NULL
pre-B	NULL
cell	NULL
lines	NULL
,	NULL
mock/300-19	NULL
and	NULL
CD70/300-19	NULL
,	NULL
did	NULL
not	NULL
express	NULL
mRNA	NULL
for	NULL
human	NULL
PRDI-BF1	NULL
,	NULL
BSAP	NULL
,	NULL
or	NULL
B	NULL
,	NULL
m	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
indicate	NULL
that	NULL
while	NULL
CD27/CD70	NULL
interaction	NULL
does	NULL
not	NULL
reduce	NULL
the	NULL
expression	NULL
of	NULL
BSAP	NULL
,	NULL
it	NULL
promotes	NULL
the	NULL
generation	NULL
of	NULL
plasma	NULL
cells	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
up-regulating	NULL
PRDI-BF1	NULL
levels	NULL
.	NULL

Discussion	NULL
B	NULL
cell	NULL
IgE	NULL
production	NULL
is	NULL
regulated	NULL
by	NULL
cytokines	NULL
such	NULL
as	NULL
IL-4	NULL
(	NULL
29-31	NULL
)	NULL
and	NULL
IL-13	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
and	NULL
by	NULL
direct	NULL
contact	NULL
between	NULL
B	NULL
and	NULL
Th	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
29	NULL
,	NULL
32	NULL
,	NULL
33	NULL
)	NULL
,	NULL
in	NULL
which	NULL
€CD40/CD154	NULL
interaction	NULL
is	NULL
important	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Gascan	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
both	NULL
anti-CD40	NULL
and	NULL
the	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
clones	NULL
to	NULL
purified	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
had	NULL
synergistic	NULL
effects	NULL
on	NULL
IgE	NULL
synthesis	NULL
,	NULL
suggesting	NULL
that	NULL
different	NULL
B	NULL
cell	NULL
activation	NULL
pathways	NULL
can	NULL
result	NULL
in	NULL
IgE	NULL
switching	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Life	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
also	NULL
suggested	NULL
the	NULL
involvement	NULL
of	NULL
T	NULL
cell	NULL
surface	NULL
molecules	NULL
,	NULL
other	NULL
than	NULL
CD154	NULL
,	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IgE	NULL
synthesis	NULL
,	NULL
because	NULL
T	NULL
cell	NULL
clones	NULL
with	NULL
nonfunctional	NULL
CD154	NULL
molecules	NULL
obtained	NULL
from	NULL
X-linked	NULL
hyper-IgM	NULL
syndrome	NULL
patients	NULL
induced	NULL
IgE	NULL
synthesis	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
,	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
can	NULL
be	NULL
separated	NULL
by	NULL
CD27	NULL
expression	NULL
,	NULL
and	NULL
CD27	NULL
*	NULL
B	NULL
cells	NULL
produce	NULL
IgA	NULL
,	NULL
IgM	NULL
,	NULL
and	NULL
IgG	NULL
,	NULL
which	NULL
are	NULL
augmented	NULL
with	NULL
CD70	NULL
transfectants	NULL
by	NULL
promoting	NULL
their	NULL
differentiation	NULL
into	NULL
Ab-secreting	NULL
cells	NULL
in	NULL
various	NULL
B	NULL
cell	NULL
stimulation	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
systems	NULL
(	NULL
17	NULL
,	NULL
18	NULL
,	NULL
27	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
prompted	NULL
us	NULL
to	NULL
ascertain	NULL
whether	NULL
CD27/CD70	NULL
interaction	NULL
participates	NULL
in	NULL
B	NULL
cell	NULL
IgE	NULL
synthesis	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
IL-4	NULL
has	NULL
a	NULL
potent	NULL
function	NULL
in	NULL
the	NULL
production	NULL
of	NULL
IgE	NULL
by	NULL
B	NULL
cells	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
IL-4	NULL
alone	NULL
induces	NULL
B	NULL
cell	NULL
germline	NULL
e	NULL
transcripts	NULL
but	NULL
not	NULL
IgE	NULL
production	NULL
.	NULL

By	NULL
the	NULL
addition	NULL
of	NULL
CD40	NULL
signaling	NULL
to	NULL
IL-4	NULL
,	NULL
the	NULL
mature	NULL
e	NULL
transcripts	NULL
can	NULL
be	NULL
induced	NULL
,	NULL
and	NULL
IgE	NULL
synthesis	NULL
finally	NULL
occurs	NULL
(	NULL
4	NULL
,	NULL
3	NULL
,	NULL
26	NULL
)	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
,	NULL
CD70	NULL
transfectants	NULL
significantly	NULL
augmented	NULL
IgE	NULL
production	NULL
by	NULL
highly	NULL
purified	NULL
B	NULL
cells	NULL
cultured	NULL
with	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
.	NULL

Since	NULL
the	NULL
blockage	NULL
of	NULL
CD27/CD70	NULL
interaction	NULL
by	NULL
mAb	NULL
completely	NULL
blocks	NULL
the	NULL
augmentation	NULL
of	NULL
B	NULL
cell	NULL
IgE	NULL
production	NULL
by	NULL
CD70	NULL
transfectants	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
CD27	NULL
signaling	NULL
evidently	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
IgE	NULL
synthesis	NULL
.	NULL

When	NULL
we	NULL
used	NULL
highly	NULL
purified	NULL
CD27	NULL
*	NULL
B	NULL
cells	NULL
,	NULL
their	NULL
IgE	NULL
production	NULL
was	NULL
increased	NULL
more	NULL
than	NULL
that	NULL
of	NULL
unseparated	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
,	NULL
whereas	NULL
CD27	NULL
B	NULL
cells	NULL
did	NULL
not	NULL
entirely	NULL
produce	NULL
IgE	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
support	NULL
the	NULL
view	NULL
that	NULL
CD27	NULL
*	NULL
B	NULL
cells	NULL
are	NULL
primed	NULL
memory	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
CD27	NULL
~	NULL
B	NULL
cells	NULL
are	NULL
unprimed	NULL
naive	NULL
B	NULL
cells	NULL
as	NULL
we	NULL
previously	NULL
demonstrated	NULL
in	NULL
the	NULL
synthesis	NULL
of	NULL
IgA	NULL
,	NULL
IgM	NULL
,	NULL
and	NULL
IgG	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Several	NULL
reports	NULL
indicated	NULL
that	NULL
CD70	NULL
transfectants	NULL
induced	NULL
B	NULL
cell	NULL
proliferation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SAC	NULL
plus	NULL
IL-2	NULL
(	NULL
15	NULL
,	NULL
16	NULL
,	NULL
18	NULL
)	NULL
.	NULL

In	NULL
our	NULL
experiment	NULL
,	NULL
CD70	NULL
transfectants	NULL
augmented	NULL
B	NULL
cell	NULL
proliferation	NULL
to	NULL
about	NULL
3	NULL
times	NULL
that	NULL
found	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

In	NULL
disagreement	NULL
with	NULL
our	NULL
data	NULL
,	NULL
Jumper	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
stimulation	NULL
via	NULL
CD27	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
or	NULL
IL-4	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
role	NULL
of	NULL
CD70	NULL
in	NULL
regulating	NULL
B	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
is	NULL
questionable	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
reasons	NULL
for	NULL
the	NULL
discrepancy	NULL
in	NULL
B	NULL
cell	NULL
proliferation	NULL
via	NULL
CD27	NULL
between	NULL
the	NULL
reported	NULL
data	NULL
(	NULL
36	NULL
)	NULL
and	NULL
our	NULL
present	NULL
results	NULL
are	NULL
not	NULL
clear	NULL
,	NULL
but	NULL
several	NULL
possibilities	NULL
could	NULL
be	NULL
postulated	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
the	NULL
degree	NULL
of	NULL
the	NULL
CD70	NULL
expression	NULL
of	NULL
the	NULL
transfectants	NULL
may	NULL
be	NULL
different	NULL
;	NULL
CD70	NULL
expression	NULL
of	NULL
our	NULL
transfectants	NULL
is	NULL
prominent	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
reported	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
concentrations	NULL
of	NULL
cytokines	NULL
used	NULL
in	NULL
the	NULL
studies	NULL
are	NULL
probably	NULL
different	NULL
between	NULL
the	NULL
two	NULL
studies	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
B	NULL
cell	NULL
proliferation	NULL
in	NULL
our	NULL
system	NULL
using	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
were	NULL
very	NULL
low	NULL
compared	NULL
with	NULL
the	NULL
proliferation	NULL
effects	NULL
previously	NULL
reported	NULL
(	NULL
36	NULL
)	NULL
.	NULL

As	NULL
cross-linking	NULL
of	NULL
anti-CD40	NULL
by	NULL
CD32	NULL
transfectants	NULL
or	NULL
soluble	NULL
€CD154	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
greatly	NULL
promoted	NULL
B	NULL
cell	NULL
proliferation	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
our	NULL
stimulation	NULL
systems	NULL
with	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
alone	NULL
appear	NULL
to	NULL
be	NULL
suboptimal	NULL
.	NULL

Enhancement	NULL
of	NULL
B	NULL
cell	NULL
proliferation	NULL
by	NULL
CD70	NULL
transfectants	NULL
were	NULL
remarkable	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
,	NULL
but	NULL
were	NULL
not	NULL
prominent	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
plus	NULL
CD32	NULL
transfectants	NULL
or	NULL
IL-4	NULL
plus	NULL
soluble	NULL
CD154	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
present	NULL
suboptimal	NULL
activation	NULL
system	NULL
is	NULL
suitable	NULL
for	NULL
observing	NULL
the	NULL
enhancing	NULL
effects	NULL
of	NULL
CD27/CD70	NULL
interaction	NULL
on	NULL
B	NULL
cell	NULL
proliferation	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
IgE	NULL
synthesis	NULL
was	NULL
not	NULL
as	NULL
significantly	NULL
increased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-€CD40	NULL
plus	NULL
CD32	NULL
transfectants	NULL
or	NULL
IL-4	NULL
plus	NULL
soluble	NULL
CD154	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
.	NULL

The	NULL
enhancement	NULL
of	NULL
IgE	NULL
synthesis	NULL
via	NULL
CD27	NULL
signaling	NULL
was	NULL
most	NULL
significant	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
.	NULL

B	NULL
cell	NULL
IgE	NULL
synthesis	NULL
is	NULL
preceded	NULL
by	NULL
transcription	NULL
of	NULL
the	NULL
germline	NULL
e	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
relationship	NULL
between	NULL
this	NULL
expression	NULL
and	NULL
subsequent	NULL
switching	NULL
to	NULL
Ce	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

CD20	NULL
*	NULL
CD27	NULL
*	NULL
and	NULL
CD20*	NULL
CD27~	NULL
B	NULL
cells	NULL
from	NULL
healthy	NULL
adults	NULL
did	NULL
not	NULL
differentiate	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
produce	NULL
e	NULL
transcripts	NULL
by	NULL
exogenous	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
IL-4-induced	NULL
e	NULL
transcripts	NULL
occur	NULL
similarly	NULL
in	NULL
CD20*	NULL
CD27~	NULL
naive	NULL
B	NULL
cell	NULL
and	NULL
CD20+*	NULL
CD27+*	NULL
B	NULL
cell	NULL
popula-tions	NULL
.	NULL

Jumper	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
demonstrated	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
CD70	NULL
transfectants	NULL
into	NULL
EBV-transformed	NULL
B	NULL
cells	NULL
did	NULL
not	NULL
augment	NULL
the	NULL
germline	NULL
e	NULL
expression	NULL
.	NULL

Also	NULL
,	NULL
triggering	NULL
via	NULL
CD27	NULL
by	NULL
CD70	NULL
in	NULL
the	NULL
present	NULL
study	NULL
exerted	NULL
no	NULL
enhancing	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
germline	NULL
e	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

6501	NULL
These	NULL
findings	NULL
suggested	NULL
that	NULL
CD27/CD70	NULL
interaction	NULL
does	NULL
not	NULL
participate	NULL
in	NULL
the	NULL
IL-4-induced	NULL
germline	NULL
e	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
one	NULL
possibility	NULL
remains	NULL
that	NULL
CD27	NULL
signaling	NULL
may	NULL
induce	NULL
IgE	NULL
class	NULL
switching	NULL
following	NULL
the	NULL
increase	NULL
in	NULL
germline	NULL
e	NULL
transcripts	NULL
with	NULL
IL-4	NULL
or	NULL
IL-4	NULL
plus	NULL
€D40	NULL
signaling	NULL
.	NULL

To	NULL
clarify	NULL
this	NULL
point	NULL
,	NULL
we	NULL
performed	NULL
quantitative	NULL
RT-PCR	NULL
using	NULL
mature	NULL
e	NULL
primers	NULL
.	NULL

Unfortu-nately	NULL
,	NULL
as	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
mature	NULL
e	NULL
bands	NULL
using	NULL
several	NULL
primer	NULL
pairs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
plus	NULL
CD32	NULL
transfectants	NULL
,	NULL
we	NULL
failed	NULL
to	NULL
estimate	NULL
the	NULL
effects	NULL
of	NULL
CD27/CD70	NULL
interaction	NULL
in	NULL
the	NULL
IgE	NULL
class	NULL
switching	NULL
.	NULL

As	NULL
reported	NULL
previously	NULL
,	NULL
the	NULL
CD27	NULL
signal	NULL
resulted	NULL
in	NULL
the	NULL
terminal	NULL
differentiation	NULL
of	NULL
peripheral	NULL
blood	NULL
memory	NULL
B	NULL
cells	NULL
into	NULL
plasma	NULL
cells	NULL
in	NULL
B	NULL
cell	NULL
activation	NULL
systems	NULL
by	NULL
IL-10	NULL
or	NULL
IL-10	NULL
plus	NULL
IL-2	NULL
(	NULL
17	NULL
)	NULL
and	NULL
SAC	NULL
or	NULL
SAC	NULL
plus	NULL
IL-2	NULL
(	NULL
18	NULL
)	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
,	NULL
B	NULL
cells	NULL
also	NULL
differentiated	NULL
into	NULL
plasma	NULL
cells	NULL
by	NULL
triggering	NULL
via	NULL
CD27	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
CD154	NULL
is	NULL
expressed	NULL
on	NULL
T	NULL
cells	NULL
soon	NULL
after	NULL
the	NULL
activation	NULL
,	NULL
and	NULL
CD70	NULL
is	NULL
expressed	NULL
on	NULL
T	NULL
cells	NULL
later	NULL
after	NULL
the	NULL
activation	NULL
(	NULL
17	NULL
)	NULL
,	NULL
CD40	NULL
triggering	NULL
probably	NULL
participates	NULL
in	NULL
the	NULL
early	NULL
steps	NULL
of	NULL
the	NULL
IgE	NULL
switch	NULL
recombination	NULL
and	NULL
then	NULL
CD27/	NULL
CD70	NULL
interaction	NULL
may	NULL
promote	NULL
the	NULL
differentiation	NULL
of	NULL
class-switched	NULL
B	NULL
cells	NULL
into	NULL
IgE-producing	NULL
plasma	NULL
cells	NULL
(	NULL
35	NULL
,	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

CD40/CD154	NULL
interaction	NULL
also	NULL
induces	NULL
the	NULL
expansion	NULL
of	NULL
memory	NULL
B	NULL
cells	NULL
expressing	NULL
CD27	NULL
on	NULL
the	NULL
surface	NULL
.	NULL

CD27	NULL
may	NULL
be	NULL
important	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
plasma	NULL
cells	NULL
when	NULL
the	NULL
expansion	NULL
of	NULL
CD27-positive	NULL
B	NULL
cells	NULL
has	NULL
already	NULL
occurred	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
we	NULL
demonstrated	NULL
here	NULL
and	NULL
previously	NULL
,	NULL
CD27	NULL
is	NULL
crucial	NULL
in	NULL
controlling	NULL
the	NULL
differentiation	NULL
of	NULL
all	NULL
isotype-committed	NULL
memory	NULL
B	NULL
cells	NULL
into	NULL
plasma	NULL
cells	NULL
.	NULL

PRDI-BF1/Blimp-1	NULL
,	NULL
a	NULL
recently	NULL
described	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
various	NULL
steps	NULL
of	NULL
B	NULL
cell	NULL
terminal	NULL
differentiation	NULL
(	NULL
28	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
its	NULL
expression	NULL
participates	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
plasma	NULL
cells	NULL
.	NULL

Since	NULL
CD27	NULL
cross-linking	NULL
on	NULL
B	NULL
cells	NULL
enhanced	NULL
the	NULL
mRNA	NULL
expression	NULL
of	NULL
PRDI-BF1/Blimp-1	NULL
,	NULL
even	NULL
after	NULL
the	NULL
overnight	NULL
activation	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
plasma	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
demonstrated	NULL
by	NULL
FACS	NULL
,	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
PRDI-BF1/Blimp-1	NULL
induced	NULL
by	NULL
CD27/CD70	NULL
interaction	NULL
.	NULL

We	NULL
also	NULL
investigated	NULL
the	NULL
transcription	NULL
factor	NULL
BSAP/Pax-5	NULL
,	NULL
which	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
B	NULL
cell	NULL
proliferation	NULL
,	NULL
because	NULL
it	NULL
is	NULL
expressed	NULL
in	NULL
all	NULL
B	NULL
cell	NULL
developmental	NULL
stages	NULL
except	NULL
for	NULL
the	NULL
plasma	NULL
cell	NULL
stage	NULL
(	NULL
41	NULL
)	NULL
.	NULL

BSAP	NULL
mRNA	NULL
expression	NULL
was	NULL
unexpectedly	NULL
up-regulated	NULL
by	NULL
triggering	NULL
via	NULL
CD27	NULL
on	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
large	NULL
majority	NULL
of	NULL
the	NULL
cultured	NULL
cells	NULL
in	NULL
our	NULL
system	NULL
was	NULL
composed	NULL
of	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
plasma	NULL
cells	NULL
constituted	NULL
a	NULL
small	NULL
population	NULL
,	NULL
even	NULL
after	NULL
8	NULL
days	NULL
of	NULL
culture	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
remaining	NULL
B	NULL
cells	NULL
may	NULL
express	NULL
BSAP	NULL
.	NULL

At	NULL
least	NULL
,	NULL
CD27/CD70	NULL
interaction	NULL
on	NULL
B	NULL
cells	NULL
did	NULL
not	NULL
directly	NULL
reduce	NULL
BSAP	NULL
expression	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
CD70	NULL
transfectants	NULL
significantly	NULL
augmented	NULL
IgE	NULL
production	NULL
from	NULL
highly	NULL
purified	NULL
B	NULL
cells	NULL
,	NULL
especially	NULL
CD27	NULL
*	NULL
B	NULL
cells	NULL
cultured	NULL
with	NULL
IL-4	NULL
plus	NULL
anti-CD40	NULL
,	NULL
by	NULL
enhancing	NULL
B	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
into	NULL
plasma	NULL
cells	NULL
without	NULL
any	NULL
increase	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
germline	NULL
e.	NULL
Our	NULL
findings	NULL
presented	NULL
in	NULL
this	NULL
paper	NULL
should	NULL
be	NULL
tested	NULL
in	NULL
the	NULL
murine	NULL
system	NULL
including	NULL
CD27	NULL
'~	NULL
mutant	NULL
mice	NULL
(	NULL
42	NULL
)	NULL
,	NULL
although	NULL
the	NULL
effects	NULL
of	NULL
CD27/CD70	NULL
interaction	NULL
on	NULL
B	NULL
cell	NULL
Ig	NULL
synthesis	NULL
in	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
systems	NULL
are	NULL
somewhat	NULL
different	NULL
(	NULL
J.	NULL
Borst	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Experiments	NULL
to	NULL
examine	NULL
these	NULL
aspects	NULL
are	NULL
underway	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Drs	NULL
.	NULL

S.	NULL
Nonoyama	NULL
,	NULL
T.	NULL
Kobata	NULL
,	NULL
and	NULL
C.	NULL
Morimoto	NULL
for	NULL
support	NULL
.	NULL

References	NULL
1.	NULL
de	NULL
Weck	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Stanworth	NULL
.	NULL

1974	NULL
.	NULL

I.	NULL
Anaphylactic	NULL
hypersensitivity	NULL
:	NULL
introduction	NULL
.	NULL

In	NULL
Progress	NULL
in	NULL
Immunology	NULL
.	NULL

L.	NULL
Brent	NULL
and	NULL
J.	NULL
Holborow	NULL
,	NULL
eds	NULL
.	NULL

North	NULL
Holland	NULL
,	NULL
Amsterdam	NULL
,	NULL
p.	NULL
4	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6502	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22.	NULL
.	NULL

Gauchat	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
D.	NULL
A.	NULL
Lebman	NULL
,	NULL
R.	NULL
L.	NULL
Coffman	NULL
,	NULL
H.	NULL
Gascan	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
.	NULL

1990	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
germline	NULL
e	NULL
transcripts	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
induced	NULL
by	NULL
interleukin	NULL
4	NULL
to	NULL
switch	NULL
to	NULL
IgE	NULL
production	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:463.	NULL
.	NULL

Jabara	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
S.	NULL
M.	NULL
Fu	NULL
,	NULL
R.	NULL
S.	NULL
Geha	NULL
,	NULL
and	NULL
D.	NULL
Vercelli	NULL
.	NULL

1990	NULL
.	NULL

CD40	NULL
and	NULL
IgE	NULL
:	NULL
synergism	NULL
between	NULL
anti-	NULL
CD40	NULL
monoclonal	NULL
antibody	NULL
and	NULL
interleukin	NULL
4	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IgE	NULL
synthesis	NULL
by	NULL
highly	NULL
purified	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172	NULL
;	NULL
1861.	NULL
.	NULL

Gascan	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
F.	NULL
Gauchat	NULL
,	NULL
G.	NULL
Aversa	NULL
,	NULL
P.	NULL
Van	NULL
Vlasselaer	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
.	NULL

1991	NULL
.	NULL

Anti-CD40	NULL
monoclonal	NULL
antibodies	NULL
or	NULL
CD4*	NULL
T	NULL
cell	NULL
clones	NULL
and	NULL
IL-4	NULL
induce	NULL
IgG4	NULL
and	NULL
IgE	NULL
switching	NULL
in	NULL
purified	NULL
human	NULL
B	NULL
cells	NULL
via	NULL
different	NULL
signaling	NULL
pathways	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:8.	NULL
.	NULL

Punnonen	NULL
,	NULL
J.	NULL
,	NULL
G.	NULL
Aversa	NULL
,	NULL
B.	NULL
G.	NULL
Cocks	NULL
,	NULL
A.	NULL
N.	NULL
McKenzie	NULL
,	NULL
S.	NULL
Menon	NULL
,	NULL
G.	NULL
Zurawski	NULL
,	NULL
R.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
.	NULL

1993	NULL
.	NULL

Interleukin	NULL
13	NULL
induces	NULL
interleukin	NULL
4-independent	NULL
IgG4	NULL
and	NULL
IgB	NULL
synthesis	NULL
and	NULL
CD23	NULL
expression	NULL
by	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:3730.	NULL
.	NULL

McKenzie	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Culpepper	NULL
,	NULL
R.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
F.	NULL
Briere	NULL
,	NULL
J.	NULL
Punnonen	NULL
,	NULL
G.	NULL
Aversa	NULL
,	NULL
A.	NULL
Sato	NULL
,	NULL
W.	NULL
Dang	NULL
,	NULL
B.	NULL
G.	NULL
Cocks	NULL
,	NULL
S.	NULL
Menon	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Interleukin	NULL
13	NULL
,	NULL
a	NULL
T-cell-derived	NULL
cytokine	NULL
that	NULL
regulates	NULL
human	NULL
monocyte	NULL
and	NULL
B-cell	NULL
function	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:3735.	NULL
.	NULL

Barrett	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
G.	NULL
Shu	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Clark	NULL
.	NULL

1991	NULL
.	NULL

CD40	NULL
signaling	NULL
activates	NULL
CD11a/	NULL
CD18	NULL
(	NULL
LFA-1	NULL
)	NULL
-mediated	NULL
adhesion	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1722.	NULL
.	NULL

Life	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
F.	NULL
Gauchat	NULL
,	NULL
V.	NULL
Schnuriger	NULL
,	NULL
S.	NULL
Estoppey	NULL
,	NULL
G.	NULL
Mazzei	NULL
,	NULL
A.	NULL
Durandy	NULL
,	NULL
A.	NULL
Fischer	NULL
,	NULL
and	NULL
J.	NULL
Y.	NULL
Bonnefoy	NULL
.	NULL

1994	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
from	NULL
an	NULL
X-linked	NULL
hyper-immunoglobulin	NULL
(	NULL
IgM	NULL
)	NULL
patient	NULL
induce	NULL
IgE	NULL
synthesis	NULL
in	NULL
vitro	NULL
despite	NULL
expression	NULL
of	NULL
nonfunctional	NULL
CD40	NULL
ligand	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1775.	NULL
.	NULL

van	NULL
Lier	NULL
,	NULL
R.	NULL
A.	NULL
W.	NULL
,	NULL
J.	NULL
Borst	NULL
,	NULL
T.	NULL
M.	NULL
Vroom	NULL
,	NULL
H.	NULL
Klein	NULL
,	NULL
P.	NULL
Van	NULL
Mourik	NULL
,	NULL
W.	NULL
P.	NULL
Zeijlemaker	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
M.	NULL
Melief	NULL
.	NULL

1987	NULL
.	NULL

Tissue	NULL
distribution	NULL
and	NULL
biochemical	NULL
and	NULL
functional	NULL
properties	NULL
of	NULL
TpS5S5	NULL
(	NULL
CD27	NULL
)	NULL
,	NULL
a	NULL
novel	NULL
T	NULL
cell	NULL
differentiation	NULL
antigen	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139:1589	NULL
.	NULL

Hintzen	NULL
,	NULL
R.	NULL
Q.	NULL
,	NULL
R.	NULL
de	NULL
Jong	NULL
,	NULL
S.	NULL
M.	NULL
Lens	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
W.	NULL
van	NULL
Lier	NULL
.	NULL

1994	NULL
.	NULL

CD27	NULL
:	NULL
marker	NULL
and	NULL
mediator	NULL
of	NULL
T-cell	NULL
activation	NULL
?	NULL

Immunol	NULL
.	NULL

Today	NULL
15:307.	NULL
van	NULL
Oers	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
S.	NULL
T.	NULL
Pals	NULL
,	NULL
L.	NULL
M.	NULL
Evers	NULL
,	NULL
C.	NULL
E.	NULL
van	NULL
der	NULL
Schoot	NULL
,	NULL
G.	NULL
Koopman	NULL
,	NULL
J.	NULL
M.	NULL
Bonfrer	NULL
,	NULL
R.	NULL
Q.	NULL
Hintzen	NULL
,	NULL
A.	NULL
E.	NULL
von	NULL
dem	NULL
Borne	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
W.	NULL
van	NULL
Lier	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
and	NULL
release	NULL
of	NULL
CD27	NULL
in	NULL
human	NULL
B-cell	NULL
malignancies	NULL
.	NULL

Blood	NULL
82:3430	NULL
.	NULL

Camerini	NULL
,	NULL
D.	NULL
,	NULL
G.	NULL
Walz	NULL
,	NULL
W.	NULL
A.	NULL
M.	NULL
Loenen	NULL
,	NULL
J.	NULL
Borst	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
activation	NULL
antigen	NULL
CD27	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
nerve	NULL
growth	NULL
factor/tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
gene	NULL
family	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:3165	NULL
.	NULL

Goodwin	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
M.	NULL
R.	NULL
Alderson	NULL
,	NULL
C.	NULL
A.	NULL
Smith	NULL
,	NULL
R.	NULL
J.	NULL
Armitage	NULL
,	NULL
T.	NULL
VandenBos	NULL
,	NULL
R.	NULL
Jerzy	NULL
,	NULL
T.	NULL
W.	NULL
Tough	NULL
,	NULL
M.	NULL
A.	NULL
Schoenborn	NULL
,	NULL
T.	NULL
Davis-Smith	NULL
,	NULL
K.	NULL
Hennen	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
and	NULL
biochemical	NULL
characterization	NULL
of	NULL
a	NULL
ligand	NULL
for	NULL
CD27	NULL
defines	NULL
a	NULL
new	NULL
family	NULL
of	NULL
cytokines	NULL
with	NULL
homology	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Cell	NULL
73:447	NULL
.	NULL

Agematsu	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Kobata	NULL
,	NULL
K.	NULL
Sugita	NULL
,	NULL
T.	NULL
Hirose	NULL
,	NULL
S.	NULL
F.	NULL
Schlossman	NULL
,	NULL
and	NULL
C.	NULL
Morimoto	NULL
.	NULL

1995	NULL
.	NULL

Direct	NULL
cellular	NULL
communication	NULL
between	NULL
CD4SRO	NULL
and	NULL
CD45RA	NULL
T	NULL
cell	NULL
subset	NULL
via	NULL
€D27/CD70	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:3627	NULL
.	NULL

Agematsu	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Kobata	NULL
,	NULL
F.	NULL
C.	NULL
Yang	NULL
,	NULL
T.	NULL
Nakazawa	NULL
,	NULL
K.	NULL
Fukushima	NULL
,	NULL
M.	NULL
Kitahara	NULL
,	NULL
T.	NULL
Mori	NULL
,	NULL
K.	NULL
Sugita	NULL
,	NULL
C.	NULL
Morimoto	NULL
,	NULL
and	NULL
A.	NULL
Komiyama	NULL
.	NULL

1995	NULL
.	NULL

CD27/CD70	NULL
interaction	NULL
directly	NULL
drives	NULL
B	NULL
cell	NULL
IgG	NULL
and	NULL
IgM	NULL
synthesis	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:2825	NULL
.	NULL

Kobata	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Jacquot	NULL
,	NULL
S.	NULL
Kozlowski	NULL
,	NULL
K.	NULL
Agematsu	NULL
,	NULL
S.	NULL
F.	NULL
Schlossman	NULL
,	NULL
and	NULL
C.	NULL
Morimoto	NULL
.	NULL

1995	NULL
.	NULL

CD27-CD70	NULL
interactions	NULL
regulate	NULL
B-cell	NULL
activation	NULL
by	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11249	NULL
.	NULL

Agematsu	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Nagumo	NULL
,	NULL
Y.	NULL
Oguchi	NULL
,	NULL
T.	NULL
Nakazawa	NULL
,	NULL
K.	NULL
Fukushima	NULL
,	NULL
K.	NULL
Yasui	NULL
,	NULL
S.	NULL
Ito	NULL
,	NULL
T.	NULL
Kobata	NULL
,	NULL
C.	NULL
Morimoto	NULL
,	NULL
and	NULL
A.	NULL
Komiyama	NULL
.	NULL

1998	NULL
.	NULL

Generation	NULL
of	NULL
plasma	NULL
cells	NULL
from	NULL
peripheral	NULL
blood	NULL
memory	NULL
B	NULL
cells	NULL
:	NULL
synergistic	NULL
effect	NULL
of	NULL
IL-10	NULL
and	NULL
CD27/CD70	NULL
interaction	NULL
.	NULL

Blood	NULL
91:173	NULL
.	NULL

Jacquot	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Kobata	NULL
,	NULL
S.	NULL
Iwata	NULL
,	NULL
C.	NULL
Morimoto	NULL
,	NULL
and	NULL
S.	NULL
F.	NULL
Schlossman	NULL
.	NULL

1997	NULL
.	NULL

CD154/CD40	NULL
and	NULL
CD70/CD27	NULL
interactions	NULL
have	NULL
different	NULL
and	NULL
sequential	NULL
functions	NULL
in	NULL
T	NULL
cell-dependent	NULL
B	NULL
cell	NULL
responses	NULL
:	NULL
enhancement	NULL
of	NULL
plasma	NULL
cell	NULL
differentiation	NULL
by	NULL
CD27	NULL
signaling	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:2652	NULL
.	NULL

Sugita	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Hirose	NULL
,	NULL
D.	NULL
M.	NULL
Rothstein	NULL
,	NULL
C.	NULL
Donahue	NULL
,	NULL
S.	NULL
F.	NULL
Schlossman	NULL
,	NULL
and	NULL
C.	NULL
Morimoto	NULL
.	NULL

1992	NULL
.	NULL

CD27	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
nerve	NULL
growth	NULL
factor	NULL
receptor	NULL
family	NULL
,	NULL
is	NULL
preferentially	NULL
expressed	NULL
on	NULL
CD4SRA*	NULL
CD4	NULL
T	NULL
cell	NULL
clones	NULL
and	NULL
involved	NULL
in	NULL
distinct	NULL
immunoregulatory	NULL
functions	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:3208	NULL
.	NULL

Morimoto	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
L.	NULL
Letvin	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Distaso	NULL
,	NULL
W.	NULL
R.	NULL
Aldrich	NULL
,	NULL
and	NULL
S.	NULL
F.	NULL
Schlossman	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
isolation	NULL
of	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
suppressor	NULL
inducer	NULL
T	NULL
cell	NULL
subsct	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

134:1508	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
;	NULL
156	NULL
.	NULL

Takebe	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
P.	NULL
Hoy	NULL
,	NULL
K.	NULL
Yokota	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1988	NULL
.	NULL

SRa	NULL
promoter	NULL
:	NULL
an	NULL
effect	NULL
and	NULL
versatile	NULL
mammalian	NULL
cDNA	NULL
ex	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

AUGMENTATION	NULL
OF	NULL
IgE	NULL
SYNTHESIS	NULL
BY	NULL
CD27/CD70	NULL
pressed	NULL
system	NULL
composed	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
and	NULL
the	NULL
R-US	NULL
segment	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:466	NULL
.	NULL

Streuli	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Morimoto	NULL
,	NULL
M.	NULL
Schricber	NULL
,	NULL
S.	NULL
F.	NULL
Schlossman	NULL
,	NULL
and	NULL
H.	NULL
Saito	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
CD45	NULL
and	NULL
CD4SR	NULL
monoclonal	NULL
antibodies	NULL
using	NULL
transfected	NULL
mouse	NULL
cell	NULL
lines	NULL
that	NULL
express	NULL
individual	NULL
human	NULL
leukocyte	NULL
common	NULL
antigen	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

141:3910	NULL
.	NULL

Gussow	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
Rein	NULL
,	NULL
I.	NULL
Ginjaar	NULL
,	NULL
F.	NULL
Hochstenbach	NULL
,	NULL
G.	NULL
Seema	NULL
,	NULL
A.	NULL
Kottman	NULL
,	NULL
and	NULL
H.	NULL
L.	NULL
Ploegh	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
human	NULL
B2-microglobulin	NULL
gene	NULL
:	NULL
primary	NULL
structure	NULL
and	NULL
definition	NULL
of	NULL
the	NULL
transcription	NULL
unit	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139:3132	NULL
.	NULL

Nagumo	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
K.	NULL
Agematsu	NULL
.	NULL

1998	NULL
.	NULL

Synergistic	NULL
augmentative	NULL
effect	NULL
on	NULL
IL-10	NULL
and	NULL
CD27/CD70	NULL
interactions	NULL
on	NULL
B	NULL
cell	NULL
immunoglobulin	NULL
synthesis	NULL
.	NULL

Immunology	NULL
94:388	NULL
.	NULL

Kawabe	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Naka	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Fujiwara	NULL
,	NULL
S.	NULL
Sucmatsu	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
H.	NULL
Kikutani	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
immune	NULL
responses	NULL
in	NULL
CD4O-deficient	NULL
mice	NULL
:	NULL
impaired	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
and	NULL
germinal	NULL
center	NULL
formation	NULL
.	NULL

Immunity	NULL
1:167	NULL
.	NULL

Agematsu	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Nagumo	NULL
,	NULL
F.	NULL
C.	NULL
Yang	NULL
,	NULL
T.	NULL
Nakazawa	NULL
,	NULL
K.	NULL
Fukushima	NULL
,	NULL
S.	NULL
Ito	NULL
,	NULL
K.	NULL
Sugita	NULL
,	NULL
T.	NULL
Mori	NULL
,	NULL
T.	NULL
Kobata	NULL
,	NULL
C.	NULL
Morimoto	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

B	NULL
cell	NULL
subpopulations	NULL
separated	NULL
by	NULL
CD27	NULL
and	NULL
crucial	NULL
collaboration	NULL
of	NULL
CD27	NULL
B	NULL
cell	NULL
and	NULL
helper	NULL
T	NULL
cell	NULL
in	NULL
the	NULL
immunoglobulin	NULL
production	NULL
.	NULL

Kur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:2073	NULL
.	NULL

Turmer	NULL
,	NULL
C.	NULL
,	NULL
Jr.	NULL
,	NULL
D.	NULL
H.	NULL
Mack	NULL
,	NULL
and	NULL
M.	NULL
M.	NULL
Davis	NULL
.	NULL

1994	NULL
.	NULL

Blimp-1	NULL
,	NULL
a	NULL
novel	NULL
zinc	NULL
finger-containing	NULL
protein	NULL
that	NULL
can	NULL
drive	NULL
the	NULL
maturation	NULL
of	NULL
B	NULL
lymphocytes	NULL
into	NULL
immunoglobulin-secreting	NULL
cells	NULL
.	NULL

Cell	NULL
77:297	NULL
.	NULL

Parronchi	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Tiri	NULL
,	NULL
D.	NULL
Macchia	NULL
,	NULL
M.	NULL
De	NULL
Carli	NULL
,	NULL
P.	NULL
Biswas	NULL
,	NULL
C.	NULL
Simonelli	NULL
,	NULL
E.	NULL
Maggi	NULL
,	NULL
G.	NULL
Del	NULL
Prete	NULL
,	NULL
M.	NULL
Ricci	NULL
,	NULL
and	NULL
S.	NULL
Romagnani	NULL
.	NULL

1990	NULL
.	NULL

Noncognate	NULL
contact-dependent	NULL
B	NULL
cell	NULL
activation	NULL
can	NULL
promote	NULL
IL-4-dependent	NULL
in	NULL
vitro	NULL
human	NULL
IgE	NULL
synthesis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:2102	NULL
.	NULL

Claassen	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
A.	NULL
D.	NULL
Levine	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Buckley	NULL
.	NULL

1990	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-4	NULL
induces	NULL
IgE	NULL
and	NULL
IgG	NULL
synthesis	NULL
by	NULL
normal	NULL
and	NULL
atopic	NULL
donor	NULL
mononuclear	NULL
cells	NULL
:	NULL
similar	NULL
dose	NULL
response	NULL
,	NULL
time	NULL
course	NULL
,	NULL
requirement	NULL
for	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
effect	NULL
of	NULL
pokeweed	NULL
mitogen	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:2123	NULL
.	NULL

Jabara	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
L.	NULL
C.	NULL
Schneider	NULL
,	NULL
S.	NULL
K.	NULL
Shapira	NULL
,	NULL
C.	NULL
Alfieri	NULL
,	NULL
C.	NULL
T.	NULL
Moody	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
R.	NULL
S.	NULL
Geha	NULL
,	NULL
and	NULL
D.	NULL
Vercelli	NULL
.	NULL

1990	NULL
.	NULL

Induction	NULL
of	NULL
germ-line	NULL
and	NULL
mature	NULL
Ce	NULL
transcripts	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-4	NULL
and	NULL
EBV	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:3468	NULL
.	NULL

Vercelli	NULL
,	NULL
D.	NULL
,	NULL
H.	NULL
H.	NULL
Jabara	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Geha	NULL
.	NULL

1989	NULL
.	NULL

Induction	NULL
of	NULL
human	NULL
IgE	NULL
synthesis	NULL
requires	NULL
interleukin	NULL
4	NULL
and	NULL
T/B	NULL
cell	NULL
interactions	NULL
involving	NULL
the	NULL
T	NULL
cell	NULL
receptor/CD3	NULL
complex	NULL
and	NULL
MHC	NULL
class	NULL
II	NULL
antigens	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169:1295	NULL
.	NULL

DeKruyff	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
T.	NULL
Turner	NULL
,	NULL
J.	NULL
S.	NULL
Abrams	NULL
,	NULL
M.	NULL
Palladino	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Umetsu	NULL
.	NULL

1989	NULL
.	NULL

Induction	NULL
of	NULL
human	NULL
IgE	NULL
synthesis	NULL
by	NULL
CD4*	NULL
T	NULL
cell	NULL
clones	NULL
:	NULL
requirement	NULL
for	NULL
interleukin	NULL
4	NULL
and	NULL
low	NULL
molecular	NULL
weight	NULL
B	NULL
cell	NULL
growth	NULL
factor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170	NULL
:	NULL
1477	NULL
.	NULL

Snapper	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
F.	NULL
D.	NULL
Finkelman	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1988	NULL
.	NULL

Regulation	NULL
of	NULL
IgG1	NULL
and	NULL
IgE	NULL
production	NULL
by	NULL
interleukin	NULL
4	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

102:51	NULL
.	NULL

Banchereau	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
De	NULL
Paoli	NULL
,	NULL
A.	NULL
Valle	NULL
,	NULL
E.	NULL
Garcia	NULL
,	NULL
and	NULL
F.	NULL
Rousset	NULL
.	NULL

1991	NULL
.	NULL

Long-term	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
dependent	NULL
on	NULL
interleukin-4	NULL
and	NULL
antibody	NULL
to	NULL
CD40	NULL
.	NULL

Science	NULL
251:70	NULL
.	NULL

Jumper	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Y.	NULL
Nishioka	NULL
,	NULL
L.	NULL
S.	NULL
Davis	NULL
,	NULL
P.	NULL
E.	NULL
Lipsky	NULL
,	NULL
and	NULL
K.	NULL
Meck	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
B	NULL
cell	NULL
function	NULL
by	NULL
recombinant	NULL
CD40	NULL
ligand	NULL
and	NULL
other	NULL
TNF-related	NULL
ligands	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:2369	NULL
.	NULL

Shapira	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
D.	NULL
Vercelli	NULL
,	NULL
H.	NULL
H.	NULL
Jabara	NULL
,	NULL
S.	NULL
M.	NULL
Fu	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Geha	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
immunoglobulin	NULL
E	NULL
synthesis	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
by	NULL
interleukin	NULL
4	NULL
and	NULL
engagement	NULL
of	NULL
CD40	NULL
antigen	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:289	NULL
.	NULL

Zhang	NULL
,	NULL
K.	NULL
,	NULL
E.	NULL
A.	NULL
Clark	NULL
,	NULL
and	NULL
A.	NULL
Saxon	NULL
.	NULL

1991	NULL
.	NULL

CD40	NULL
stimulation	NULL
provides	NULL
an	NULL
IFN-y-independent	NULL
and	NULL
IL-4-dependent	NULL
differentiation	NULL
signal	NULL
directly	NULL
to	NULL
human	NULL
B	NULL
cells	NULL
for	NULL
IgE	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1836	NULL
.	NULL

Jumper	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Splawski	NULL
,	NULL
P.	NULL
E.	NULL
Lipsky	NULL
,	NULL
and	NULL
K.	NULL
Meck	NULL
.	NULL

1994	NULL
.	NULL

Ligation	NULL
of	NULL
CD40	NULL
induces	NULL
sterile	NULL
transcripts	NULL
of	NULL
multiple	NULL
Ig	NULL
H	NULL
chain	NULL
isotypes	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:438	NULL
.	NULL

Arpin	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Dechanet	NULL
,	NULL
C.	NULL
Van	NULL
Kooten	NULL
,	NULL
P.	NULL
Merville	NULL
,	NULL
G.	NULL
Grouard	NULL
,	NULL
F.	NULL
Briere	NULL
,	NULL
J.	NULL
Banchereau	NULL
,	NULL
and	NULL
Y.	NULL
J.	NULL
Liu	NULL
.	NULL

1995	NULL
.	NULL

Generation	NULL
of	NULL
memory	NULL
B	NULL
cells	NULL
and	NULL
plasma	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Science	NULL
268:720	NULL
.	NULL

Wakatsuki	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
F.	NULL
Neurath	NULL
,	NULL
E.	NULL
E.	NULL
Max	NULL
,	NULL
and	NULL
W.	NULL
Strober	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
BSAP	NULL
regulates	NULL
B	NULL
cell	NULL
proliferation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:1099	NULL
.	NULL

Gravestein	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
W.	NULL
van	NULL
Ewijk	NULL
,	NULL
F.	NULL
Ossendorp	NULL
,	NULL
and	NULL
J.	NULL
Borst	NULL
.	NULL

1996	NULL
.	NULL

CD27	NULL
coop-crates	NULL
with	NULL
the	NULL
pre-T	NULL
cell	NULL
receptor	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
murine	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:675	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

